ONTOLOGY REPORT - ANNOTATIONS
| Term: | bis(2-chloroethyl) sulfide |
|
| Accession: | CHEBI:25434
|
browse the term
|
| Definition: | An ethyl sulfide that has formula C4H8Cl2S. |
| Synonyms: | exact_synonym: | 1-chloro-2-[(2-chloroethyl)sulfanyl]ethane |
| | related_synonym: | 1,1'-thiobis(2-chloroethane); 1-chloro-2-[(2-chloroethyl)thio]ethane; C4H8Cl2S; ClCCSCCCl; InChI=1S/C4H8Cl2S/c5-1-3-7-4-2-6/h1-4H2; InChIKey=QKSKPIVNLNLAAV-UHFFFAOYSA-N; Lost; Senfgas; Yperite; bis(2-chloroethyl) sulphide; bis(2-chloroethyl)sulfane; mustard gas; sulfur mustard |
| | xref_casrn: | 505-60-2 |
| | xref: | ChEMBL:554448 "ChEMBL COMPOUND"; ChemIDplus:1733595 "Beilstein Registry Number"; ChemIDplus:505-60-2 "CAS Registry Number"; Gmelin:324535 "Gmelin Registry Number" |
| | xref_mesh: | MESH:D009151 |
| | xref: | NIST Chemistry WebBook:505-60-2 "CAS Registry Number" |
|
|
bis(2-chloroethyl) sulfide
|
| G |
Abi1 |
abl-interactor 1 |
|
increases expression |
ISO |
17 |
96,576,331 |
96,648,752 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
increases expression |
ISO |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
decreases expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
affects response to substance |
ISO |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
affects expression |
EXP |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
increases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adam10 |
ADAM metallopeptidase domain 10 |
|
increases expression |
ISO |
8 |
75,200,657 |
75,289,572 |
RGD:6480464 |
CTD |
| G |
Adam3a |
ADAM metallopeptidase domain 3A |
|
increases expression |
ISO |
16 |
71,729,856 |
71,779,922 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
affects expression |
EXP |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Adat1 |
adenosine deaminase, tRNA-specific 1 |
|
increases expression |
ISO |
19 |
41,902,820 |
41,926,545 |
RGD:6480464 |
CTD |
| G |
Adcy6 |
adenylate cyclase 6 |
|
decreases expression |
ISO |
7 |
137,339,933 |
137,360,020 |
RGD:6480464 |
CTD |
| G |
Adcy7 |
adenylate cyclase 7 |
|
increases expression |
ISO |
19 |
20,051,639 |
20,073,861 |
RGD:6480464 |
CTD |
| G |
Adk |
adenosine kinase |
|
affects expression |
EXP |
15 |
3,071,412 |
3,458,891 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
increases expression |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
increases expression |
ISO |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
increases expression |
ISO |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
increases expression |
ISO |
1 |
82,686,233 |
82,726,544 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
affects binding |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases alkylation |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases alkylation |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases expression |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases alkylation |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases alkylation |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
affects expression |
EXP |
1 |
185,970,658 |
185,974,615 |
RGD:6480464 |
CTD |
| G |
Alox12 |
arachidonate 12-lipoxygenase |
|
increases expression |
ISO |
10 |
57,080,603 |
57,092,874 |
RGD:6480464 |
CTD |
| G |
Alx4 |
ALX homeobox 4 |
|
increases expression |
ISO |
3 |
78,057,714 |
78,094,285 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
increases expression |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
increases expression |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apcs |
amyloid P component, serum |
|
increases expression |
ISO |
13 |
89,112,845 |
89,113,641 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
decreases expression |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Arf6 |
ADP-ribosylation factor 6 |
|
affects expression |
EXP |
6 |
91,337,496 |
91,338,644 |
RGD:6480464 |
CTD |
| G |
Arl15 |
ADP-ribosylation factor-like 15 |
|
affects expression |
EXP |
2 |
45,450,287 |
45,706,518 |
RGD:6480464 |
CTD |
| G |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
|
increases expression |
ISO |
1 |
140,535,823 |
140,646,838 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
increases phosphorylation |
ISO |
3 |
56,403,676 |
56,496,473 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
affects expression |
EXP |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 |
|
increases expression |
ISO |
7 |
118,537,718 |
118,538,994 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 |
|
affects expression |
EXP |
7 |
118,537,718 |
118,538,994 |
RGD:6480464 |
CTD |
| G |
Atoh7 |
atonal homolog 7 (Drosophila) |
|
increases expression |
ISO |
20 |
25,448,296 |
25,448,745 |
RGD:6480464 |
CTD |
| G |
Atp6v0a2 |
ATPase, H+ transporting, lysosomal V0 subunit A2 |
|
increases expression |
ISO |
12 |
33,061,611 |
33,092,421 |
RGD:6480464 |
CTD |
| G |
B4galt6 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 |
|
increases expression |
ISO |
18 |
12,421,062 |
12,478,276 |
RGD:6480464 |
CTD |
| G |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
|
increases expression |
ISO |
11 |
27,467,207 |
27,500,173 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
decreases phosphorylation |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Barhl1 |
BarH-like homeobox 1 |
|
increases expression |
ISO |
3 |
7,917,842 |
7,925,164 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
affects expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bclaf1 |
BCL2-associated transcription factor 1 |
|
increases phosphorylation |
ISO |
1 |
15,605,220 |
15,632,005 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
increases expression |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bmf |
Bcl2 modifying factor |
|
increases expression |
ISO |
3 |
104,966,652 |
104,984,752 |
RGD:6480464 |
CTD |
| G |
Bmp1 |
bone morphogenetic protein 1 |
|
decreases expression |
ISO |
15 |
50,878,144 |
50,922,313 |
RGD:6480464 |
CTD |
| G |
Bmp6 |
bone morphogenetic protein 6 |
|
increases expression |
ISO |
17 |
32,380,199 |
32,689,295 |
RGD:6480464 |
CTD |
| G |
Bmpr1b |
bone morphogenetic protein receptor, type IB |
|
increases expression |
ISO |
2 |
239,727,569 |
239,767,802 |
RGD:6480464 |
CTD |
| G |
Bsg |
basigin (Ok blood group) |
|
increases expression |
ISO |
7 |
11,507,914 |
11,515,132 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
C5ar1 |
complement component 5a receptor 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cacnb2 |
calcium channel, voltage-dependent, beta 2 subunit |
|
affects expression |
EXP |
17 |
88,832,905 |
89,078,870 |
RGD:6480464 |
CTD |
| G |
Calcr |
calcitonin receptor |
|
decreases expression |
ISO |
4 |
28,486,176 |
28,561,296 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
multiple interactions |
ISO |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
increases expression |
ISO |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
|
increases expression |
ISO |
14 |
86,632,686 |
86,721,281 |
RGD:6480464 |
CTD |
| G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
|
decreases expression |
ISO |
18 |
25,404,123 |
25,625,785 |
RGD:6480464 |
CTD |
| G |
Canx |
calnexin |
|
increases phosphorylation |
ISO |
10 |
35,850,944 |
35,883,494 |
RGD:6480464 |
CTD |
| G |
Capn3 |
calpain 3 |
|
increases expression |
ISO |
3 |
106,946,878 |
106,998,274 |
RGD:6480464 |
CTD |
| G |
Capn5 |
calpain 5 |
|
decreases expression |
ISO |
1 |
155,366,678 |
155,421,183 |
RGD:6480464 |
CTD |
| G |
Capn6 |
calpain 6 |
|
increases expression |
ISO |
X |
34,697,658 |
34,722,369 |
RGD:6480464 |
CTD |
| G |
Caprin1 |
cell cycle associated protein 1 |
|
increases expression |
ISO |
3 |
89,062,097 |
89,093,093 |
RGD:6480464 |
CTD |
| G |
Car6 |
carbonic anhydrase 6 |
|
increases expression |
ISO |
5 |
167,332,219 |
167,350,880 |
RGD:6480464 |
CTD |
| G |
Cask |
calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
|
affects expression |
EXP |
X |
20,910,960 |
21,250,869 |
RGD:6480464 |
CTD |
| G |
Casp2 |
caspase 2 |
|
increases activity |
ISO |
4 |
70,029,728 |
70,047,164 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
multiple interactions |
ISO |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
multiple interactions |
ISO |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
multiple interactions |
ISO |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
increases activity |
ISO |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases activity |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases expression |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases expression |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8ap2 |
caspase 8 associated protein 2 |
|
increases expression |
ISO |
5 |
48,920,175 |
48,958,139 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
increases expression |
ISO |
10 |
70,279,161 |
70,283,762 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
increases expression |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
increases expression |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
increases expression |
ISO |
10 |
71,759,643 |
71,761,115 |
RGD:6480464 |
CTD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
increases expression |
ISO |
10 |
71,759,643 |
71,761,115 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
increases expression |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl6 |
chemokine (C-C motif) ligand 6 |
|
increases expression |
ISO |
10 |
71,660,623 |
71,665,255 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
increases expression |
ISO |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccl9 |
chemokine (C-C motif) ligand 9 |
|
increases expression |
ISO |
10 |
71,645,931 |
71,650,814 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
increases expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
increases expression |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
increases expression |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
affects expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
ISO |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
ISO |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng2 |
cyclin G2 |
|
increases expression |
ISO |
14 |
16,338,132 |
16,346,628 |
RGD:6480464 |
CTD |
| G |
Ccnl1 |
cyclin L1 |
|
affects expression |
EXP |
2 |
155,757,335 |
155,769,633 |
RGD:6480464 |
CTD |
| G |
Ccnl1 |
cyclin L1 |
|
increases expression |
ISO |
2 |
155,757,335 |
155,769,633 |
RGD:6480464 |
CTD |
| G |
Ccnt1 |
cyclin T1 |
|
increases expression |
ISO |
7 |
137,288,635 |
137,314,809 |
RGD:6480464 |
CTD |
| G |
Ccr1 |
chemokine (C-C motif) receptor 1 |
|
increases expression |
ISO |
8 |
128,693,658 |
128,699,213 |
RGD:6480464 |
CTD |
| G |
Ccr1 |
chemokine (C-C motif) receptor 1 |
|
increases expression |
ISO |
8 |
128,693,658 |
128,699,213 |
RGD:6480464 |
CTD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
increases expression |
ISO |
8 |
128,892,784 |
128,893,905 |
RGD:6480464 |
CTD |
| G |
Ccr5 |
chemokine (C-C motif) receptor 5 |
|
increases expression |
ISO |
8 |
128,907,157 |
128,912,272 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
increases expression |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
increases expression |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd22 |
CD22 molecule |
|
increases expression |
ISO |
1 |
85,923,707 |
85,938,567 |
RGD:6480464 |
CTD |
| G |
Cd247 |
Cd247 molecule |
|
increases expression |
ISO |
13 |
81,515,383 |
81,594,699 |
RGD:6480464 |
CTD |
| G |
Cd27 |
CD27 molecule |
|
increases expression |
ISO |
4 |
161,351,797 |
161,356,688 |
RGD:6480464 |
CTD |
| G |
Cd28 |
Cd28 molecule |
|
increases expression |
ISO |
9 |
59,342,273 |
59,367,743 |
RGD:6480464 |
CTD |
| G |
Cd4 |
Cd4 molecule |
|
increases expression |
ISO |
4 |
160,988,512 |
161,014,038 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
decreases expression |
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
increases expression |
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cd40lg |
CD40 ligand |
|
multiple interactions |
ISO |
X |
141,925,019 |
141,937,183 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
increases expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
increases expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd47 |
Cd47 molecule |
|
increases expression |
ISO |
11 |
52,098,355 |
52,158,169 |
RGD:6480464 |
CTD |
| G |
Cd53 |
Cd53 molecule |
|
increases expression |
ISO |
2 |
202,186,125 |
202,234,570 |
RGD:6480464 |
CTD |
| G |
Cd7 |
Cd7 molecule |
|
increases expression |
ISO |
10 |
110,250,174 |
110,253,055 |
RGD:6480464 |
CTD |
| G |
Cd93 |
CD93 molecule |
|
increases expression |
ISO |
3 |
137,188,528 |
137,193,457 |
RGD:6480464 |
CTD |
| G |
Cdc25b |
cell division cycle 25B |
|
increases expression |
ISO |
3 |
118,893,716 |
118,903,516 |
RGD:6480464 |
CTD |
| G |
Cdh15 |
cadherin 15 |
|
increases expression |
ISO |
19 |
53,182,536 |
53,194,779 |
RGD:6480464 |
CTD |
| G |
Cdh8 |
cadherin 8 |
|
increases expression |
ISO |
19 |
5,685,862 |
6,014,208 |
RGD:6480464 |
CTD |
| G |
Cdk14 |
cyclin-dependent kinase 14 |
|
affects expression |
EXP |
4 |
25,352,280 |
25,942,686 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
affects expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdx1 |
caudal type homeo box 1 |
|
increases expression |
ISO |
18 |
56,983,284 |
57,006,721 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Celf2 |
CUGBP, Elav-like family member 2 |
|
increases expression |
ISO |
17 |
82,708,354 |
83,025,139 |
RGD:6480464 |
CTD |
| G |
Cer1 |
cerberus 1, DAN family BMP antagonist |
|
increases expression |
ISO |
5 |
101,756,095 |
101,759,451 |
RGD:6480464 |
CTD |
| G |
Cetn2 |
centrin, EF-hand protein, 2 |
|
decreases expression |
ISO |
X |
158,917,650 |
158,923,210 |
RGD:6480464 |
CTD |
| G |
Cfb |
complement factor B |
|
increases expression |
ISO |
20 |
4,072,124 |
4,077,802 |
RGD:6480464 |
CTD |
| G |
Chd1 |
chromodomain helicase DNA binding protein 1 |
|
increases expression |
ISO |
1 |
54,594,860 |
54,631,157 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
increases expression |
ISO |
12 |
45,933,900 |
45,965,427 |
RGD:6480464 |
CTD |
| G |
Chst15 |
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
|
decreases expression |
ISO |
1 |
191,708,603 |
191,737,958 |
RGD:6480464 |
CTD |
| G |
Cish |
cytokine inducible SH2-containing protein |
|
increases expression |
ISO |
8 |
112,541,034 |
112,545,982 |
RGD:6480464 |
CTD |
| G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
|
multiple interactions |
ISO |
1 |
206,802,745 |
206,806,332 |
RGD:6480464 |
CTD |
| G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
|
increases expression |
ISO |
1 |
206,802,745 |
206,806,332 |
RGD:6480464 |
CTD |
| G |
Cngb3 |
cyclic nucleotide gated channel beta 3 |
|
increases expression |
ISO |
5 |
33,867,639 |
34,136,940 |
RGD:6480464 |
CTD |
| G |
Cntn1 |
contactin 1 |
|
increases expression |
ISO |
7 |
130,658,836 |
130,845,071 |
RGD:6480464 |
CTD |
| G |
Cntn4 |
contactin 4 |
|
increases expression |
ISO |
4 |
141,199,447 |
142,055,176 |
RGD:6480464 |
CTD |
| G |
Commd3 |
COMM domain containing 3 |
|
affects expression |
EXP |
17 |
92,775,474 |
92,779,187 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
increases expression |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases expression |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
increases expression |
ISO |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
increases expression |
ISO |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csf3r |
colony stimulating factor 3 receptor (granulocyte) |
|
increases expression |
ISO |
5 |
145,374,596 |
145,394,045 |
RGD:6480464 |
CTD |
| G |
Csf3r |
colony stimulating factor 3 receptor (granulocyte) |
|
decreases expression |
ISO |
5 |
145,374,596 |
145,394,045 |
RGD:6480464 |
CTD |
| G |
Csrnp1 |
cysteine-serine-rich nuclear protein 1 |
|
affects expression |
EXP |
8 |
124,933,472 |
124,939,576 |
RGD:6480464 |
CTD |
| G |
Csrp2 |
cysteine and glycine-rich protein 2 |
|
increases expression |
ISO |
7 |
49,910,235 |
49,929,536 |
RGD:6480464 |
CTD |
| G |
Ctbp1 |
C-terminal binding protein 1 |
|
affects expression |
EXP |
14 |
83,022,824 |
83,050,335 |
RGD:6480464 |
CTD |
| G |
Ctbp2 |
C-terminal binding protein 2 |
|
affects expression |
EXP |
1 |
192,463,615 |
192,492,935 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
|
increases expression |
ISO |
4 |
110,747,551 |
111,922,482 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
affects expression |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cux1 |
cut-like homeobox 1 |
|
affects expression |
EXP |
12 |
21,223,919 |
21,516,938 |
RGD:6480464 |
CTD |
| G |
Cux1 |
cut-like homeobox 1 |
|
increases expression |
ISO |
12 |
21,223,919 |
21,516,938 |
RGD:6480464 |
CTD |
| G |
Cux2 |
cut-like homeobox 2 |
|
increases expression |
ISO |
12 |
35,850,093 |
35,910,414 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
increases expression |
ISO |
9 |
73,470,943 |
73,477,315 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects expression |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
increases expression |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
increases expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyth1 |
cytohesin 1 |
|
increases expression |
ISO |
10 |
108,189,311 |
108,253,419 |
RGD:6480464 |
CTD |
| G |
Dbh |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
increases expression |
ISO |
3 |
6,052,706 |
6,069,826 |
RGD:6480464 |
CTD |
| G |
Dbp |
D site of albumin promoter (albumin D-box) binding protein |
|
decreases expression |
ISO |
1 |
96,173,573 |
96,178,485 |
RGD:6480464 |
CTD |
| G |
Dcc |
deleted in colorectal carcinoma |
|
increases expression |
ISO |
18 |
68,026,795 |
69,140,741 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Dffa |
DNA fragmentation factor, alpha subunit |
|
increases cleavage |
ISO |
5 |
166,179,130 |
166,192,029 |
RGD:6480464 |
CTD |
| G |
Diaph2 |
diaphanous-related formin 2 |
|
affects expression |
EXP |
X |
116,641,770 |
117,258,314 |
RGD:6480464 |
CTD |
| G |
Dlg1 |
discs, large homolog 1 (Drosophila) |
|
affects expression |
EXP |
11 |
70,735,283 |
70,930,374 |
RGD:6480464 |
CTD |
| G |
Dlx2 |
distal-less homeobox 2 |
|
increases expression |
ISO |
3 |
53,852,209 |
53,854,092 |
RGD:6480464 |
CTD |
| G |
Dlx4 |
distal-less homeobox 4 |
|
increases expression |
ISO |
10 |
83,822,815 |
83,828,210 |
RGD:6480464 |
CTD |
| G |
Dlx6 |
distal-less homeobox 6 |
|
increases expression |
ISO |
4 |
31,764,068 |
31,768,050 |
RGD:6480464 |
CTD |
| G |
Dmbt1 |
deleted in malignant brain tumors 1 |
|
increases expression |
ISO |
1 |
190,378,428 |
190,470,536 |
RGD:6480464 |
CTD |
| G |
Dmd |
dystrophin |
|
decreases expression |
ISO |
X |
71,501,362 |
71,671,414 |
RGD:6480464 |
CTD |
| G |
Dnaja2 |
DnaJ (Hsp40) homolog, subfamily A, member 2 |
|
increases expression |
ISO |
19 |
22,853,702 |
22,871,846 |
RGD:6480464 |
CTD |
| G |
Dnajb4 |
DnaJ (Hsp40) homolog, subfamily B, member 4 |
|
affects expression |
EXP |
2 |
250,663,022 |
250,685,242 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
increases expression |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dntt |
DNA nucleotidylexotransferase |
|
increases expression |
ISO |
1 |
246,199,856 |
246,231,792 |
RGD:6480464 |
CTD |
| G |
Dock1 |
dedicator of cyto-kinesis 1 |
|
affects expression |
EXP |
1 |
194,172,914 |
194,795,629 |
RGD:6480464 |
CTD |
| G |
Dock9 |
dedicator of cytokinesis 9 |
|
affects expression |
EXP |
15 |
106,629,808 |
106,787,895 |
RGD:6480464 |
CTD |
| G |
Dpagt1 |
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) |
|
increases expression |
ISO |
8 |
47,305,087 |
47,311,488 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
affects expression |
EXP |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Dsc2 |
desmocollin 2 |
|
increases expression |
ISO |
18 |
11,902,185 |
11,933,989 |
RGD:6480464 |
CTD |
| G |
Dsg3 |
desmoglein 3 |
|
increases expression |
ISO |
18 |
12,253,043 |
12,291,911 |
RGD:6480464 |
CTD |
| G |
Dym |
dymeclin |
|
affects expression |
EXP |
18 |
71,889,053 |
72,188,251 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
increases expression |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
Ebf1 |
early B-cell factor 1 |
|
increases expression |
ISO |
10 |
29,770,047 |
30,163,200 |
RGD:6480464 |
CTD |
| G |
Edar |
ectodysplasin-A receptor |
|
increases expression |
ISO |
20 |
37,135,534 |
37,164,197 |
RGD:6480464 |
CTD |
| G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
|
decreases expression |
ISO |
3 |
170,295,327 |
170,304,505 |
RGD:6480464 |
CTD |
| G |
Eef2k |
eukaryotic elongation factor-2 kinase |
|
decreases expression |
ISO |
1 |
179,712,404 |
179,754,345 |
RGD:6480464 |
CTD |
| G |
Eef2k |
eukaryotic elongation factor-2 kinase |
|
increases phosphorylation |
ISO |
1 |
179,712,404 |
179,754,345 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
increases expression |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr2 |
early growth response 2 |
|
increases expression |
ISO |
20 |
21,883,885 |
21,888,177 |
RGD:6480464 |
CTD |
| G |
Ehbp1 |
EH domain binding protein 1 |
|
affects expression |
EXP |
14 |
102,732,009 |
102,951,294 |
RGD:6480464 |
CTD |
| G |
Ei24 |
etoposide induced 2.4 |
|
increases expression |
ISO |
8 |
38,028,043 |
38,044,316 |
RGD:6480464 |
CTD |
| G |
Ei24 |
etoposide induced 2.4 |
|
affects expression |
EXP |
8 |
38,028,043 |
38,044,316 |
RGD:6480464 |
CTD |
| G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
increases phosphorylation |
ISO |
2 |
147,870,265 |
147,903,411 |
RGD:6480464 |
CTD |
| G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
increases expression |
ISO |
4 |
104,016,940 |
104,078,261 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
increases expression |
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma, 1 |
|
increases phosphorylation |
ISO |
11 |
82,451,555 |
82,471,735 |
RGD:6480464 |
CTD |
| G |
Eif5b |
eukaryotic translation initiation factor 5B |
|
increases phosphorylation |
ISO |
9 |
36,937,415 |
36,993,650 |
RGD:6480464 |
CTD |
| G |
Elf3 |
E74-like factor 3 |
|
increases expression |
ISO |
13 |
48,258,893 |
48,263,713 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
affects expression |
EXP |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Enpep |
glutamyl aminopeptidase |
|
increases expression |
ISO |
2 |
226,731,079 |
226,732,069 |
RGD:6480464 |
CTD |
| G |
Entpd3 |
ectonucleoside triphosphate diphosphohydrolase 3 |
|
increases expression |
ISO |
8 |
125,542,934 |
125,573,945 |
RGD:6480464 |
CTD |
| G |
Eomes |
eomesodermin |
|
increases expression |
ISO |
8 |
123,376,689 |
123,383,451 |
RGD:6480464 |
CTD |
| G |
Ep300 |
E1A binding protein p300 |
|
decreases expression |
ISO |
7 |
119,938,507 |
120,008,886 |
RGD:6480464 |
CTD |
| G |
Epas1 |
endothelial PAS domain protein 1 |
|
increases expression |
ISO |
6 |
10,203,108 |
10,297,215 |
RGD:6480464 |
CTD |
| G |
Epb41l1 |
erythrocyte membrane protein band 4.1-like 1 |
|
increases phosphorylation |
ISO |
3 |
146,876,451 |
146,944,603 |
RGD:6480464 |
CTD |
| G |
Epha2 |
Eph receptor A2 |
|
affects expression |
EXP |
5 |
160,185,143 |
160,214,727 |
RGD:6480464 |
CTD |
| G |
Epor |
erythropoietin receptor |
|
increases expression |
ISO |
8 |
21,061,310 |
21,065,886 |
RGD:6480464 |
CTD |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
multiple interactions |
ISO |
9 |
66,843,898 |
67,967,970 |
RGD:6480464 |
CTD |
| G |
Espn |
espin |
|
increases expression |
ISO |
5 |
169,349,723 |
169,382,076 |
RGD:6480464 |
CTD |
| G |
Ets2 |
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) |
|
increases expression |
ISO |
11 |
36,014,047 |
36,030,833 |
RGD:6480464 |
CTD |
| G |
Etv4 |
ets variant 4 |
|
increases expression |
ISO |
10 |
90,808,439 |
90,824,019 |
RGD:6480464 |
CTD |
| G |
Exoc4 |
exocyst complex component 4 |
|
increases expression |
ISO |
4 |
60,406,942 |
61,284,294 |
RGD:6480464 |
CTD |
| G |
Eya1 |
eyes absent homolog 1 (Drosophila) |
|
increases expression |
ISO |
5 |
4,132,825 |
4,276,837 |
RGD:6480464 |
CTD |
| G |
Eya2 |
eyes absent homolog 2 (Drosophila) |
|
decreases expression |
ISO |
3 |
156,731,490 |
156,848,691 |
RGD:6480464 |
CTD |
| G |
Eya3 |
eyes absent homolog 3 (Drosophila) |
|
increases expression |
ISO |
5 |
152,427,552 |
152,507,813 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
decreases expression |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
Fadd |
Fas (TNFRSF6)-associated via death domain |
|
multiple interactions |
ISO |
1 |
205,010,363 |
205,012,768 |
RGD:6480464 |
CTD |
| G |
Fadd |
Fas (TNFRSF6)-associated via death domain |
|
increases expression |
ISO |
1 |
205,010,363 |
205,012,768 |
RGD:6480464 |
CTD |
| G |
Fancc |
Fanconi anemia, complementation group C |
|
decreases expression |
ISO |
17 |
7,254,528 |
7,341,500 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
multiple interactions |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fbn1 |
fibrillin 1 |
|
decreases expression |
ISO |
3 |
112,608,480 |
112,804,118 |
RGD:6480464 |
CTD |
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
increases expression |
ISO |
13 |
86,809,011 |
86,823,599 |
RGD:6480464 |
CTD |
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
increases expression |
ISO |
13 |
86,809,011 |
86,823,599 |
RGD:6480464 |
CTD |
| G |
Fchsd2 |
FCH and double SH3 domains 2 |
|
affects expression |
EXP |
1 |
158,548,830 |
158,782,422 |
RGD:6480464 |
CTD |
| G |
Fdxr |
ferredoxin reductase |
|
increases expression |
ISO |
10 |
105,342,684 |
105,351,374 |
RGD:6480464 |
CTD |
| G |
Fgf11 |
fibroblast growth factor 11 |
|
decreases expression |
ISO |
10 |
56,619,650 |
56,622,972 |
RGD:6480464 |
CTD |
| G |
Fgf12 |
fibroblast growth factor 12 |
|
decreases expression |
ISO |
11 |
74,208,696 |
74,481,037 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
increases expression |
ISO |
1 |
96,082,475 |
96,083,718 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
decreases expression |
ISO |
3 |
113,468,427 |
113,517,538 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
multiple interactions |
ISO |
3 |
113,468,427 |
113,517,538 |
RGD:6480464 |
CTD |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
multiple interactions |
ISO |
1 |
250,951,023 |
250,956,730 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
multiple interactions |
ISO |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
affects expression |
EXP |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
decreases expression |
ISO |
14 |
82,683,191 |
82,697,229 |
RGD:6480464 |
CTD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
multiple interactions |
ISO |
14 |
82,683,191 |
82,697,229 |
RGD:6480464 |
CTD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
decreases expression |
ISO |
14 |
82,683,191 |
82,697,229 |
RGD:6480464 |
CTD |
| G |
Fgr |
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog |
|
increases expression |
ISO |
5 |
152,119,455 |
152,147,057 |
RGD:6480464 |
CTD |
| G |
Fkbp3 |
FK506 binding protein 3 |
|
increases expression |
ISO |
6 |
86,410,859 |
86,422,588 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases alkylation |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fnta |
farnesyltransferase, CAAX box, alpha |
|
affects expression |
EXP |
16 |
70,440,340 |
70,458,433 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Foxa1 |
forkhead box A1 |
|
increases expression |
ISO |
6 |
77,976,384 |
78,009,176 |
RGD:6480464 |
CTD |
| G |
Foxa2 |
forkhead box A2 |
|
increases expression |
ISO |
3 |
136,739,009 |
136,743,204 |
RGD:6480464 |
CTD |
| G |
Foxc1 |
forkhead box C1 |
|
increases expression |
ISO |
17 |
39,026,186 |
39,030,163 |
RGD:6480464 |
CTD |
| G |
Foxd4 |
forkhead box D4 |
|
increases expression |
ISO |
1 |
228,348,202 |
228,349,654 |
RGD:6480464 |
CTD |
| G |
Foxg1 |
forkhead box G1 |
|
increases expression |
ISO |
6 |
69,217,672 |
69,220,482 |
RGD:6480464 |
CTD |
| G |
Fras1 |
Fraser syndrome 1 |
|
affects expression |
EXP |
14 |
14,309,668 |
14,574,022 |
RGD:6480464 |
CTD |
| G |
Frem2 |
Fras1 related extracellular matrix protein 2 |
|
affects expression |
EXP |
2 |
142,464,169 |
142,604,059 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
increases expression |
ISO |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fst |
follistatin |
|
increases expression |
ISO |
2 |
46,542,246 |
46,550,678 |
RGD:6480464 |
CTD |
| G |
Fut8 |
fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
|
affects expression |
EXP |
6 |
99,871,195 |
100,010,833 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
decreases expression |
ISO |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
Fzd9 |
frizzled family receptor 9 |
|
decreases expression |
ISO |
12 |
22,581,510 |
22,583,824 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
increases activity |
ISO |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
increases expression |
ISO |
10 |
27,037,561 |
27,126,074 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
increases expression |
ISO |
3 |
52,789,370 |
52,830,038 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
affects expression |
EXP |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gbx2 |
gastrulation brain homeobox 2 |
|
increases expression |
ISO |
9 |
89,034,340 |
89,037,102 |
RGD:6480464 |
CTD |
| G |
Gcm1 |
glial cells missing homolog 1 (Drosophila) |
|
increases expression |
ISO |
8 |
83,018,975 |
83,032,211 |
RGD:6480464 |
CTD |
| G |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
|
increases expression |
ISO |
1 |
220,824,976 |
220,829,980 |
RGD:6480464 |
CTD |
| G |
Gdf1 |
growth differentiation factor 1 |
|
multiple interactions |
ISO |
16 |
19,580,807 |
19,596,415 |
RGD:6480464 |
CTD |
| G |
Gdf10 |
growth differentiation factor 10 |
|
decreases expression |
ISO |
16 |
9,558,781 |
9,570,656 |
RGD:6480464 |
CTD |
| G |
Gdf10 |
growth differentiation factor 10 |
|
increases expression |
ISO |
16 |
9,558,781 |
9,570,656 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
affects expression |
EXP |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gdf9 |
growth differentiation factor 9 |
|
increases expression |
ISO |
10 |
38,899,125 |
38,903,073 |
RGD:6480464 |
CTD |
| G |
Gfod1 |
glucose-fructose oxidoreductase domain containing 1 |
|
decreases expression |
ISO |
17 |
27,226,626 |
27,329,614 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
decreases expression |
ISO |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Gimap1 |
GTPase, IMAP family member 1 |
|
increases expression |
ISO |
4 |
76,829,536 |
76,833,423 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja3 |
gap junction protein, alpha 3 |
|
increases expression |
ISO |
15 |
36,052,554 |
36,078,001 |
RGD:6480464 |
CTD |
| G |
Gja5 |
gap junction protein, alpha 5 |
|
increases expression |
ISO |
2 |
191,824,118 |
191,843,867 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
increases expression |
ISO |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Gjb2 |
gap junction protein, beta 2 |
|
increases expression |
ISO |
15 |
36,153,526 |
36,159,490 |
RGD:6480464 |
CTD |
| G |
Glycam1 |
glycosylation dependent cell adhesion molecule 1 |
|
increases expression |
ISO |
7 |
142,455,642 |
142,457,902 |
RGD:6480464 |
CTD |
| G |
Gpd2 |
glycerol-3-phosphate dehydrogenase 2, mitochondrial |
|
increases expression |
ISO |
3 |
38,980,634 |
39,114,492 |
RGD:6480464 |
CTD |
| G |
Gps2 |
G protein pathway suppressor 2 |
|
increases expression |
ISO |
10 |
56,757,674 |
56,760,194 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gria1 |
glutamate receptor, ionotropic, AMPA 1 |
|
decreases expression |
ISO |
10 |
42,613,359 |
42,616,610 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
increases activity |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
increases expression |
ISO |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
decreases expression |
ISO |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
ISO |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
decreases expression |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
decreases expression |
ISO |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gtf2f1 |
general transcription factor IIF, polypeptide 1 |
|
increases phosphorylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gtf2i |
general transcription factor II I |
|
decreases expression |
ISO |
12 |
23,470,042 |
23,545,621 |
RGD:6480464 |
CTD |
| G |
Gtpbp2 |
GTP binding protein 2 |
|
increases expression |
ISO |
9 |
10,377,808 |
10,385,845 |
RGD:6480464 |
CTD |
| G |
H3f3b |
H3 histone, family 3B |
|
increases expression |
ISO |
10 |
106,130,320 |
106,132,544 |
RGD:6480464 |
CTD |
| G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
|
increases expression |
ISO |
16 |
7,073,038 |
7,108,830 |
RGD:6480464 |
CTD |
| G |
Hap1 |
huntingtin-associated protein 1 |
|
increases expression |
ISO |
10 |
89,285,396 |
89,293,631 |
RGD:6480464 |
CTD |
| G |
Hba1 |
hemoglobin, alpha 1 |
|
affects expression |
EXP |
10 |
15,584,360 |
15,585,215 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
increases expression |
ISO |
18 |
29,143,567 |
29,153,944 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
increases expression |
ISO |
18 |
29,143,567 |
29,153,944 |
RGD:6480464 |
CTD |
| G |
Hcfc1 |
host cell factor C1 |
|
increases expression |
ISO |
X |
159,875,671 |
159,900,536 |
RGD:6480464 |
CTD |
| G |
Hdac3 |
histone deacetylase 3 |
|
increases expression |
ISO |
18 |
30,857,209 |
30,875,986 |
RGD:6480464 |
CTD |
| G |
Hdgf |
hepatoma-derived growth factor |
|
increases phosphorylation |
ISO |
2 |
179,981,346 |
179,991,892 |
RGD:6480464 |
CTD |
| G |
Heph |
hephaestin |
|
increases expression |
ISO |
X |
84,033,540 |
84,138,728 |
RGD:6480464 |
CTD |
| G |
Hesx1 |
HESX homeobox 1 |
|
increases expression |
ISO |
16 |
2,255,128 |
2,257,233 |
RGD:6480464 |
CTD |
| G |
Hexb |
hexosaminidase B |
|
decreases expression |
ISO |
2 |
27,649,188 |
27,672,231 |
RGD:6480464 |
CTD |
| G |
Hexim1 |
hexamethylene bis-acetamide inducible 1 |
|
affects expression |
EXP |
10 |
92,290,289 |
92,292,401 |
RGD:6480464 |
CTD |
| G |
Hey1 |
hairy/enhancer-of-split related with YRPW motif 1 |
|
increases expression |
ISO |
2 |
95,174,030 |
95,176,430 |
RGD:6480464 |
CTD |
| G |
Hey2 |
hairy/enhancer-of-split related with YRPW motif 2 |
|
increases expression |
ISO |
1 |
27,505,117 |
27,515,204 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases expression |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hip1 |
huntingtin interacting protein 1 |
|
affects expression |
EXP |
12 |
22,287,861 |
22,422,163 |
RGD:6480464 |
CTD |
| G |
Hk1 |
hexokinase 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
affects expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmx2 |
H6 family homeobox 2 |
|
increases expression |
ISO |
1 |
191,117,643 |
191,125,304 |
RGD:6480464 |
CTD |
| G |
Hmx2 |
H6 family homeobox 2 |
|
increases expression |
ISO |
1 |
191,117,643 |
191,125,304 |
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeo box A1 |
|
increases expression |
ISO |
4 |
80,456,728 |
80,458,388 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
increases expression |
ISO |
4 |
80,542,417 |
80,546,079 |
RGD:6480464 |
CTD |
| G |
Hoxa2 |
homeo box A2 |
|
decreases expression |
ISO |
4 |
80,462,651 |
80,464,927 |
RGD:6480464 |
CTD |
| G |
Hoxa5 |
homeo box A5 |
|
increases expression |
ISO |
4 |
80,501,675 |
80,504,626 |
RGD:6480464 |
CTD |
| G |
Hoxa7 |
homeobox A7 |
|
increases expression |
ISO |
4 |
80,515,622 |
80,517,521 |
RGD:6480464 |
CTD |
| G |
Hoxa9 |
homeobox A9 |
|
increases expression |
ISO |
4 |
80,524,246 |
80,526,491 |
RGD:6480464 |
CTD |
| G |
Hoxb9 |
homeo box B9 |
|
increases expression |
ISO |
10 |
85,002,254 |
85,005,760 |
RGD:6480464 |
CTD |
| G |
Hoxc9 |
homeobox C9 |
|
increases expression |
ISO |
7 |
141,745,173 |
141,775,242 |
RGD:6480464 |
CTD |
| G |
Hoxd12 |
homeo box D12 |
|
increases expression |
ISO |
3 |
57,290,344 |
57,291,465 |
RGD:6480464 |
CTD |
| G |
Hoxd3 |
homeo box D3 |
|
increases expression |
ISO |
3 |
57,358,585 |
57,361,651 |
RGD:6480464 |
CTD |
| G |
Hoxd4 |
homeo box D4 |
|
increases expression |
ISO |
3 |
57,326,880 |
57,343,942 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
affects expression |
EXP |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
|
increases expression |
ISO |
X |
41,489,343 |
41,491,788 |
RGD:6480464 |
CTD |
| G |
Hsd17b8 |
hydroxysteroid (17-beta) dehydrogenase 8 |
|
increases expression |
ISO |
20 |
4,964,860 |
4,966,855 |
RGD:6480464 |
CTD |
| G |
Hsf2 |
heat shock transcription factor 2 |
|
increases expression |
ISO |
20 |
36,520,685 |
36,538,506 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
increases expression |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hspa4 |
heat shock protein 4 |
|
increases expression |
ISO |
10 |
38,705,629 |
38,749,058 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
|
increases expression |
ISO |
X |
31,012,921 |
31,244,127 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
increases expression |
ISO |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Idua |
iduronidase, alpha-L- |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
affects expression |
EXP |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ier5 |
immediate early response 5 |
|
affects expression |
EXP |
13 |
70,058,818 |
70,060,910 |
RGD:6480464 |
CTD |
| G |
Ifi204 |
interferon activated gene 204 |
|
increases expression |
ISO |
13 |
89,752,997 |
89,770,167 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases expression |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igbp1b |
immunoglobulin (CD79A) binding protein 1b |
|
increases expression |
ISO |
4 |
175,746,715 |
175,748,065 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
decreases expression |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
decreases expression |
ISO |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Ighmbp2 |
immunoglobulin mu binding protein 2 |
|
increases expression |
ISO |
1 |
205,792,891 |
205,815,212 |
RGD:6480464 |
CTD |
| G |
Ihh |
Indian hedgehog |
|
increases expression |
ISO |
9 |
74,287,115 |
74,293,332 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
multiple interactions |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Ikbkg |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
|
increases expression |
ISO |
X |
160,386,558 |
160,420,190 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10ra |
interleukin 10 receptor, alpha |
|
decreases expression |
ISO |
8 |
48,211,040 |
48,224,439 |
RGD:6480464 |
CTD |
| G |
Il10ra |
interleukin 10 receptor, alpha |
|
increases expression |
ISO |
8 |
48,211,040 |
48,224,439 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
increases expression |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
multiple interactions |
ISO |
10 |
39,093,512 |
39,096,069 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
decreases expression |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
affects expression |
EXP |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
affects expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1rl1 |
interleukin 1 receptor-like 1 |
|
increases expression |
ISO |
9 |
39,577,879 |
39,624,781 |
RGD:6480464 |
CTD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
increases expression |
ISO |
3 |
2,607,800 |
2,613,216 |
RGD:6480464 |
CTD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
increases expression |
ISO |
17 |
78,050,491 |
78,097,802 |
RGD:6480464 |
CTD |
| G |
Il2rb |
interleukin 2 receptor, beta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Il3 |
interleukin 3 |
|
multiple interactions |
ISO |
10 |
39,684,691 |
39,687,041 |
RGD:6480464 |
CTD |
| G |
Il33 |
interleukin 33 |
|
affects expression |
EXP |
1 |
233,670,801 |
233,685,798 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases expression |
EXP |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
decreases expression |
ISO |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
increases expression |
ISO |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
increases expression |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il5ra |
interleukin 5 receptor, alpha |
|
increases expression |
ISO |
4 |
142,067,108 |
142,098,051 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
affects expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
affects expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
affects expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6r |
interleukin 6 receptor |
|
decreases expression |
ISO |
2 |
182,078,049 |
182,128,135 |
RGD:6480464 |
CTD |
| G |
Il7r |
interleukin 7 receptor |
|
multiple interactions |
ISO |
2 |
59,103,992 |
59,128,004 |
RGD:6480464 |
CTD |
| G |
Il9 |
interleukin 9 |
|
decreases expression |
ISO |
17 |
14,068,757 |
14,071,880 |
RGD:6480464 |
CTD |
| G |
Il9r |
interleukin 9 receptor |
|
decreases expression |
ISO |
10 |
15,678,793 |
15,690,250 |
RGD:6480464 |
CTD |
| G |
Inadl |
InaD-like (Drosophila) |
|
affects expression |
EXP |
5 |
118,806,744 |
119,131,114 |
RGD:6480464 |
CTD |
| G |
Inhbe |
inhibin beta E |
|
decreases expression |
ISO |
7 |
67,308,713 |
67,310,138 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
increases expression |
ISO |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
|
increases expression |
ISO |
7 |
59,408,198 |
59,467,821 |
RGD:6480464 |
CTD |
| G |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
|
increases phosphorylation |
ISO |
6 |
111,006,957 |
111,009,305 |
RGD:6480464 |
CTD |
| G |
Isg20 |
interferon stimulated exonuclease gene 20 |
|
affects expression |
EXP |
1 |
134,631,524 |
134,637,868 |
RGD:6480464 |
CTD |
| G |
Itga2 |
integrin, alpha 2 |
|
increases expression |
ISO |
2 |
46,967,681 |
47,080,909 |
RGD:6480464 |
CTD |
| G |
Itga5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
|
increases expression |
ISO |
7 |
142,254,256 |
142,277,464 |
RGD:6480464 |
CTD |
| G |
Itga6 |
integrin, alpha 6 |
|
multiple interactions |
ISO |
3 |
54,202,931 |
54,272,803 |
RGD:6480464 |
CTD |
| G |
Itga6 |
integrin, alpha 6 |
|
decreases expression |
ISO |
3 |
54,202,931 |
54,272,803 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
increases expression |
ISO |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
increases expression |
ISO |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin, beta 2 |
|
increases expression |
ISO |
20 |
11,446,521 |
11,485,009 |
RGD:6480464 |
CTD |
| G |
Itgb4 |
integrin, beta 4 |
|
multiple interactions |
ISO |
10 |
106,080,452 |
106,116,632 |
RGD:6480464 |
CTD |
| G |
Itgb4 |
integrin, beta 4 |
|
decreases expression |
ISO |
10 |
106,080,452 |
106,116,632 |
RGD:6480464 |
CTD |
| G |
Itgb4 |
integrin, beta 4 |
|
decreases expression |
ISO |
10 |
106,080,452 |
106,116,632 |
RGD:6480464 |
CTD |
| G |
Itgb5 |
integrin, beta 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb5 |
integrin, beta 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itpr2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
|
decreases expression |
ISO |
4 |
183,677,606 |
184,066,130 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
decreases expression |
ISO |
2 |
185,556,271 |
185,558,310 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
affects expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kcnab1 |
potassium voltage-gated channel, shaker-related subfamily, beta member 1 |
|
increases expression |
ISO |
2 |
154,837,841 |
155,145,882 |
RGD:6480464 |
CTD |
| G |
Kcnb1 |
potassium voltage gated channel, Shab-related subfamily, member 1 |
|
increases expression |
ISO |
3 |
158,250,001 |
158,345,927 |
RGD:6480464 |
CTD |
| G |
Kcne1 |
potassium voltage-gated channel, Isk-related family, member 1 |
|
increases expression |
ISO |
11 |
32,344,529 |
32,355,189 |
RGD:6480464 |
CTD |
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
affects expression |
EXP |
4 |
6,192,644 |
6,224,285 |
RGD:6480464 |
CTD |
| G |
Kcnmb1 |
potassium large conductance calcium-activated channel, subfamily M, beta member 1 |
|
increases expression |
ISO |
10 |
18,904,902 |
18,912,604 |
RGD:6480464 |
CTD |
| G |
Kcnq1 |
potassium voltage-gated channel, KQT-like subfamily, member 1 |
|
affects expression |
EXP |
1 |
203,383,401 |
203,803,687 |
RGD:6480464 |
CTD |
| G |
Kcns1 |
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 |
|
increases expression |
ISO |
3 |
155,103,400 |
155,110,718 |
RGD:6480464 |
CTD |
| G |
Kcnu1 |
potassium channel, subfamily U, member 1 |
|
increases expression |
ISO |
16 |
70,517,667 |
70,604,946 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kif16b |
kinesin family member 16B |
|
multiple interactions |
ISO |
3 |
130,967,515 |
131,250,402 |
RGD:6480464 |
CTD |
| G |
Kif16b |
kinesin family member 16B |
|
decreases expression |
ISO |
3 |
130,967,515 |
131,250,402 |
RGD:6480464 |
CTD |
| G |
Kif1b |
kinesin family member 1B |
|
multiple interactions |
ISO |
5 |
166,250,225 |
166,381,782 |
RGD:6480464 |
CTD |
| G |
Kif1b |
kinesin family member 1B |
|
decreases expression |
ISO |
5 |
166,250,225 |
166,381,782 |
RGD:6480464 |
CTD |
| G |
Kif1b |
kinesin family member 1B |
|
increases expression |
ISO |
5 |
166,250,225 |
166,381,782 |
RGD:6480464 |
CTD |
| G |
Kif3c |
kinesin family member 3C |
|
increases expression |
ISO |
6 |
26,342,388 |
26,381,233 |
RGD:6480464 |
CTD |
| G |
Kifap3 |
kinesin-associated protein 3 |
|
decreases expression |
ISO |
13 |
79,544,010 |
79,673,768 |
RGD:6480464 |
CTD |
| G |
Kifap3 |
kinesin-associated protein 3 |
|
multiple interactions |
ISO |
13 |
79,544,010 |
79,673,768 |
RGD:6480464 |
CTD |
| G |
Kifc2 |
kinesin family member C2 |
|
increases expression |
ISO |
7 |
114,710,367 |
114,717,778 |
RGD:6480464 |
CTD |
| G |
Kl |
Klotho |
|
decreases expression |
ISO |
12 |
3,732,712 |
3,772,371 |
RGD:6480464 |
CTD |
| G |
Klf6 |
Kruppel-like factor 6 |
|
affects expression |
EXP |
17 |
75,578,498 |
75,585,072 |
RGD:6480464 |
CTD |
| G |
Klk6 |
kallikrein related-peptidase 6 |
|
increases expression |
ISO |
1 |
94,254,350 |
94,261,500 |
RGD:6480464 |
CTD |
| G |
Klrg1 |
killer cell lectin-like receptor subfamily G, member 1 |
|
increases expression |
ISO |
4 |
158,673,698 |
158,684,674 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
increases expression |
ISO |
7 |
140,540,960 |
140,546,186 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
increases cleavage |
ISO |
7 |
140,540,960 |
140,546,186 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
increases expression |
ISO |
7 |
140,540,960 |
140,546,186 |
RGD:6480464 |
CTD |
| G |
Krt10 |
keratin 10 |
|
increases expression |
ISO |
10 |
88,288,620 |
88,292,615 |
RGD:6480464 |
CTD |
| G |
Krt10 |
keratin 10 |
|
increases expression |
ISO |
10 |
88,288,620 |
88,292,615 |
RGD:6480464 |
CTD |
| G |
Krt14 |
keratin 14 |
|
multiple interactions |
ISO |
10 |
89,144,357 |
89,148,415 |
RGD:6480464 |
CTD |
| G |
Krt14 |
keratin 14 |
|
affects expression |
ISO |
10 |
89,144,357 |
89,148,415 |
RGD:6480464 |
CTD |
| G |
Krt14 |
keratin 14 |
|
multiple interactions |
ISO |
10 |
89,144,357 |
89,148,415 |
RGD:6480464 |
CTD |
| G |
Krt14 |
keratin 14 |
|
decreases expression |
ISO |
10 |
89,144,357 |
89,148,415 |
RGD:6480464 |
CTD |
| G |
Krt14 |
keratin 14 |
|
increases alkylation |
ISO |
10 |
89,144,357 |
89,148,415 |
RGD:6480464 |
CTD |
| G |
Krt14 |
keratin 14 |
|
decreases expression |
ISO |
10 |
89,144,357 |
89,148,415 |
RGD:6480464 |
CTD |
| G |
Krt15 |
keratin 15 |
|
decreases expression |
ISO |
10 |
89,071,915 |
89,075,732 |
RGD:6480464 |
CTD |
| G |
Krt16 |
keratin 16 |
|
increases alkylation |
ISO |
10 |
89,175,449 |
89,178,168 |
RGD:6480464 |
CTD |
| G |
Krt16 |
keratin 16 |
|
multiple interactions |
ISO |
10 |
89,175,449 |
89,178,168 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
multiple interactions |
ISO |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
increases alkylation |
ISO |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
multiple interactions |
ISO |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
increases expression |
ISO |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt5 |
keratin 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt5 |
keratin 5 |
|
increases alkylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt5 |
keratin 5 |
|
increases phosphorylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krtap15-1 |
keratin associated protein 15-1 |
|
increases expression |
ISO |
11 |
28,652,675 |
28,653,499 |
RGD:6480464 |
CTD |
| G |
Lama1 |
laminin, alpha 1 |
|
increases alkylation |
ISO |
9 |
106,855,708 |
106,980,651 |
RGD:6480464 |
CTD |
| G |
Lama2 |
laminin, alpha 2 |
|
decreases expression |
ISO |
1 |
18,203,466 |
18,885,462 |
RGD:6480464 |
CTD |
| G |
Lama3 |
laminin, alpha 3 |
|
multiple interactions |
ISO |
18 |
4,030,463 |
4,121,355 |
RGD:6480464 |
CTD |
| G |
Lama5 |
laminin, alpha 5 |
|
decreases expression |
ISO |
3 |
169,233,897 |
169,282,410 |
RGD:6480464 |
CTD |
| G |
Lamb3 |
laminin, beta 3 |
|
multiple interactions |
ISO |
13 |
109,148,815 |
109,190,322 |
RGD:6480464 |
CTD |
| G |
Lamb3 |
laminin, beta 3 |
|
increases degradation |
ISO |
13 |
109,148,815 |
109,190,322 |
RGD:6480464 |
CTD |
| G |
Lamb3 |
laminin, beta 3 |
|
increases degradation |
ISO |
13 |
109,148,815 |
109,190,322 |
RGD:6480464 |
CTD |
| G |
Lamc1 |
laminin, gamma 1 |
|
decreases expression |
ISO |
13 |
68,241,453 |
68,369,419 |
RGD:6480464 |
CTD |
| G |
Lamc2 |
laminin, gamma 2 |
|
multiple interactions |
ISO |
13 |
68,151,074 |
68,211,117 |
RGD:6480464 |
CTD |
| G |
Lamc2 |
laminin, gamma 2 |
|
decreases expression |
ISO |
13 |
68,151,074 |
68,211,117 |
RGD:6480464 |
CTD |
| G |
Lamc2 |
laminin, gamma 2 |
|
increases degradation |
ISO |
13 |
68,151,074 |
68,211,117 |
RGD:6480464 |
CTD |
| G |
Lamc2 |
laminin, gamma 2 |
|
increases degradation |
ISO |
13 |
68,151,074 |
68,211,117 |
RGD:6480464 |
CTD |
| G |
Laptm4a |
lysosomal protein transmembrane 4 alpha |
|
increases expression |
ISO |
6 |
32,410,289 |
32,427,917 |
RGD:6480464 |
CTD |
| G |
Large |
like-glycosyltransferase |
|
affects expression |
EXP |
19 |
12,043,818 |
12,497,663 |
RGD:6480464 |
CTD |
| G |
Lbp |
lipopolysaccharide binding protein |
|
increases expression |
ISO |
3 |
149,016,605 |
149,043,530 |
RGD:6480464 |
CTD |
| G |
Lcat |
lecithin cholesterol acyltransferase |
|
increases expression |
ISO |
19 |
35,781,507 |
35,784,966 |
RGD:6480464 |
CTD |
| G |
Ldb1 |
LIM domain binding 1 |
|
decreases expression |
ISO |
1 |
251,253,305 |
251,260,850 |
RGD:6480464 |
CTD |
| G |
Ldb2 |
LIM domain binding 2 |
|
increases expression |
ISO |
14 |
71,374,621 |
71,695,965 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
affects expression |
EXP |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Lef1 |
lymphoid enhancer binding factor 1 |
|
increases expression |
ISO |
2 |
228,550,263 |
228,673,131 |
RGD:6480464 |
CTD |
| G |
Lfng |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
|
decreases expression |
ISO |
12 |
14,497,704 |
14,505,723 |
RGD:6480464 |
CTD |
| G |
Lgals1 |
lectin, galactoside-binding, soluble, 1 |
|
increases expression |
ISO |
7 |
116,893,662 |
116,896,768 |
RGD:6480464 |
CTD |
| G |
Lgals7 |
lectin, galactoside-binding, soluble, 7 |
|
increases alkylation |
ISO |
1 |
83,968,263 |
83,970,018 |
RGD:6480464 |
CTD |
| G |
Lhx5 |
LIM homeobox 5 |
|
increases expression |
ISO |
12 |
37,323,820 |
37,332,257 |
RGD:6480464 |
CTD |
| G |
Lhx8 |
LIM homeobox 8 |
|
increases expression |
ISO |
2 |
252,216,608 |
252,239,112 |
RGD:6480464 |
CTD |
| G |
Lifr |
leukemia inhibitory factor receptor alpha |
|
affects expression |
EXP |
2 |
56,426,058 |
56,477,198 |
RGD:6480464 |
CTD |
| G |
Lig1 |
ligase I, DNA, ATP-dependent |
|
multiple interactions |
ISO |
1 |
73,728,892 |
73,767,429 |
RGD:6480464 |
CTD |
| G |
Lig1 |
ligase I, DNA, ATP-dependent |
|
increases activity |
ISO |
1 |
73,728,892 |
73,767,429 |
RGD:6480464 |
CTD |
| G |
Lig1 |
ligase I, DNA, ATP-dependent |
|
increases phosphorylation |
ISO |
1 |
73,728,892 |
73,767,429 |
RGD:6480464 |
CTD |
| G |
Lmna |
lamin A/C |
|
multiple interactions |
ISO |
2 |
180,595,724 |
180,616,354 |
RGD:6480464 |
CTD |
| G |
Lmna |
lamin A/C |
|
increases cleavage |
ISO |
2 |
180,595,724 |
180,616,354 |
RGD:6480464 |
CTD |
| G |
LOC686736 |
similar to H3 histone, family 3B |
|
increases expression |
ISO |
1 |
212,798,225 |
212,798,635 |
RGD:6480464 |
CTD |
| G |
Lphn2 |
latrophilin 2 |
|
affects expression |
EXP |
2 |
247,060,645 |
247,201,904 |
RGD:6480464 |
CTD |
| G |
Lpp |
LIM domain containing preferred translocation partner in lipoma |
|
affects expression |
EXP |
11 |
77,963,582 |
78,416,872 |
RGD:6480464 |
CTD |
| G |
Lrba |
LPS-responsive vesicle trafficking, beach and anchor containing |
|
affects expression |
EXP |
2 |
178,257,272 |
178,787,626 |
RGD:6480464 |
CTD |
| G |
Lrmp |
lymphoid-restricted membrane protein |
|
increases expression |
ISO |
4 |
182,769,091 |
182,823,096 |
RGD:6480464 |
CTD |
| G |
Ltb4r |
leukotriene B4 receptor |
|
increases expression |
ISO |
15 |
33,928,726 |
33,929,781 |
RGD:6480464 |
CTD |
| G |
Ltf |
lactotransferrin |
|
increases expression |
ISO |
8 |
115,417,764 |
115,440,609 |
RGD:6480464 |
CTD |
| G |
Lypla2 |
lysophospholipase II |
|
decreases expression |
ISO |
5 |
154,750,433 |
154,755,029 |
RGD:6480464 |
CTD |
| G |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) |
|
multiple interactions |
ISO |
12 |
15,312,420 |
15,323,137 |
RGD:6480464 |
CTD |
| G |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) |
|
increases expression |
ISO |
12 |
15,312,420 |
15,323,137 |
RGD:6480464 |
CTD |
| G |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) |
|
increases expression |
ISO |
12 |
15,312,420 |
15,323,137 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
increases expression |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k3 |
mitogen activated protein kinase kinase 3 |
|
increases phosphorylation |
ISO |
10 |
47,075,270 |
47,096,617 |
RGD:6480464 |
CTD |
| G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
|
increases phosphorylation |
ISO |
10 |
52,009,149 |
52,041,599 |
RGD:6480464 |
CTD |
| G |
Map2k5 |
mitogen activated protein kinase kinase 5 |
|
affects expression |
EXP |
8 |
67,313,472 |
67,542,723 |
RGD:6480464 |
CTD |
| G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
|
increases phosphorylation |
ISO |
10 |
99,859,684 |
99,974,446 |
RGD:6480464 |
CTD |
| G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
|
affects expression |
EXP |
10 |
99,859,684 |
99,974,446 |
RGD:6480464 |
CTD |
| G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
increases phosphorylation |
ISO |
12 |
1,545,407 |
1,552,353 |
RGD:6480464 |
CTD |
| G |
Map3k12 |
mitogen activated protein kinase kinase kinase 12 |
|
decreases expression |
ISO |
7 |
141,254,451 |
141,264,979 |
RGD:6480464 |
CTD |
| G |
Map3k7 |
mitogen activated protein kinase kinase kinase 7 |
|
increases expression |
ISO |
5 |
48,252,637 |
48,308,820 |
RGD:6480464 |
CTD |
| G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
|
increases expression |
ISO |
17 |
61,910,179 |
61,930,459 |
RGD:6480464 |
CTD |
| G |
Map4 |
microtubule-associated protein 4 |
|
decreases expression |
ISO |
8 |
114,300,908 |
114,438,008 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk10 |
mitogen activated protein kinase 10 |
|
increases expression |
ISO |
14 |
7,719,595 |
8,010,694 |
RGD:6480464 |
CTD |
| G |
Mapk13 |
mitogen activated protein kinase 13 |
|
decreases expression |
ISO |
20 |
7,055,313 |
7,064,405 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases expression |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases phosphorylation |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
increases expression |
ISO |
20 |
41,304,058 |
41,310,104 |
RGD:6480464 |
CTD |
| G |
Marcksl1 |
MARCKS-like 1 |
|
increases expression |
ISO |
5 |
148,669,499 |
148,672,337 |
RGD:6480464 |
CTD |
| G |
Matk |
megakaryocyte-associated tyrosine kinase |
|
increases expression |
ISO |
7 |
9,940,799 |
9,945,824 |
RGD:6480464 |
CTD |
| G |
Mc3r |
melanocortin 3 receptor |
|
increases expression |
ISO |
3 |
163,158,776 |
163,159,873 |
RGD:6480464 |
CTD |
| G |
Mc5r |
melanocortin 5 receptor |
|
decreases expression |
ISO |
18 |
64,679,384 |
64,680,417 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcpt2 |
mast cell protease 2 |
|
increases expression |
ISO |
15 |
34,556,079 |
34,558,413 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
affects expression |
EXP |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mef2a |
myocyte enhancer factor 2a |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
increases expression |
ISO |
2 |
12,331,078 |
12,346,520 |
RGD:6480464 |
CTD |
| G |
Meox2 |
mesenchyme homeobox 2 |
|
increases expression |
ISO |
6 |
55,895,760 |
55,957,066 |
RGD:6480464 |
CTD |
| G |
Mesp2 |
mesoderm posterior 2 homolog (mouse) |
|
decreases expression |
ISO |
1 |
135,590,020 |
135,592,626 |
RGD:6480464 |
CTD |
| G |
Mgat3 |
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase |
|
increases expression |
ISO |
7 |
118,429,750 |
118,457,125 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
increases expression |
ISO |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
increases expression |
ISO |
20 |
13,191,986 |
13,192,851 |
RGD:6480464 |
CTD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
decreases expression |
ISO |
20 |
13,191,986 |
13,192,851 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mnt |
max binding protein |
|
decreases expression |
ISO |
10 |
62,146,582 |
62,161,832 |
RGD:6480464 |
CTD |
| G |
Mpg |
N-methylpurine-DNA glycosylase |
|
increases response to substance |
ISO |
10 |
15,643,334 |
15,649,561 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
increases expression |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
decreases expression |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mr1 |
major histocompatibility complex, class I-related |
|
increases expression |
ISO |
13 |
70,089,637 |
70,107,384 |
RGD:6480464 |
CTD |
| G |
Mras |
muscle RAS oncogene homolog |
|
increases expression |
ISO |
8 |
104,244,660 |
104,272,556 |
RGD:6480464 |
CTD |
| G |
Mrpl23 |
mitochondrial ribosomal protein L23 |
|
increases expression |
ISO |
1 |
202,780,065 |
202,787,834 |
RGD:6480464 |
CTD |
| G |
Mrps18b |
mitochondrial ribosomal protein S18B |
|
increases expression |
ISO |
20 |
2,985,972 |
2,992,031 |
RGD:6480464 |
CTD |
| G |
Mrvi1 |
murine retrovirus integration site 1 homolog |
|
decreases expression |
ISO |
1 |
168,627,363 |
168,741,252 |
RGD:6480464 |
CTD |
| G |
Mt-nd3 |
mitochondrially encoded NADH dehydrogenase 3 |
|
increases expression |
ISO |
MT |
9,451 |
9,798 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Mycl1 |
v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian) |
|
multiple interactions |
ISO |
5 |
142,311,233 |
142,315,233 |
RGD:6480464 |
CTD |
| G |
Mycl1 |
v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian) |
|
decreases expression |
ISO |
5 |
142,311,233 |
142,315,233 |
RGD:6480464 |
CTD |
| G |
Mycs |
myc-like oncogene, s-myc protein |
|
increases expression |
ISO |
X |
28,062,010 |
28,063,302 |
RGD:6480464 |
CTD |
| G |
Myd88 |
myeloid differentiation primary response 88 |
|
increases expression |
ISO |
8 |
124,299,729 |
124,303,798 |
RGD:6480464 |
CTD |
| G |
Myf5 |
myogenic factor 5 |
|
increases expression |
ISO |
7 |
46,189,256 |
46,192,487 |
RGD:6480464 |
CTD |
| G |
Myf6 |
myogenic factor 6 |
|
increases expression |
ISO |
7 |
46,199,972 |
46,201,867 |
RGD:6480464 |
CTD |
| G |
Nab1 |
Ngfi-A binding protein 1 |
|
increases expression |
ISO |
9 |
46,084,090 |
46,124,259 |
RGD:6480464 |
CTD |
| G |
Nap1l4 |
nucleosome assembly protein 1-like 4 |
|
increases phosphorylation |
ISO |
1 |
203,890,799 |
203,926,237 |
RGD:6480464 |
CTD |
| G |
Nbn |
nibrin |
|
decreases expression |
ISO |
5 |
30,541,610 |
30,576,168 |
RGD:6480464 |
CTD |
| G |
Nckap1 |
NCK-associated protein 1 |
|
increases expression |
ISO |
3 |
63,191,700 |
63,274,021 |
RGD:6480464 |
CTD |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
affects expression |
EXP |
10 |
48,481,110 |
48,628,538 |
RGD:6480464 |
CTD |
| G |
Ndn |
necdin, melanoma antigen (MAGE) family member |
|
increases expression |
ISO |
1 |
116,594,603 |
116,596,202 |
RGD:6480464 |
CTD |
| G |
Neurod1 |
neuronal differentiation 1 |
|
increases expression |
ISO |
3 |
62,224,633 |
62,227,936 |
RGD:6480464 |
CTD |
| G |
Neurod4 |
neuronal differentiation 4 |
|
increases expression |
ISO |
7 |
8,534,957 |
8,547,130 |
RGD:6480464 |
CTD |
| G |
Neurod6 |
neuronal differentiation 6 |
|
increases expression |
ISO |
4 |
84,476,070 |
84,479,316 |
RGD:6480464 |
CTD |
| G |
Neurog3 |
neurogenin 3 |
|
increases expression |
ISO |
20 |
29,522,778 |
29,524,261 |
RGD:6480464 |
CTD |
| G |
Nf1 |
neurofibromin 1 |
|
increases expression |
ISO |
10 |
65,574,833 |
65,766,305 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfia |
nuclear factor I/A |
|
affects expression |
EXP |
5 |
118,152,938 |
118,507,056 |
RGD:6480464 |
CTD |
| G |
Nfib |
nuclear factor I/B |
|
affects expression |
EXP |
5 |
101,184,253 |
101,409,907 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbie |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
|
increases expression |
ISO |
9 |
11,044,112 |
11,050,948 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
decreases expression |
ISO |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
increases expression |
ISO |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
increases expression |
ISO |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Nhlh1 |
nescient helix loop helix 1 |
|
increases expression |
ISO |
13 |
88,047,392 |
88,052,593 |
RGD:6480464 |
CTD |
| G |
Nid1 |
nidogen 1 |
|
decreases expression |
ISO |
17 |
66,857,529 |
66,930,273 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Notch2 |
notch 2 |
|
multiple interactions |
ISO |
2 |
192,839,350 |
192,986,589 |
RGD:6480464 |
CTD |
| G |
Notch2 |
notch 2 |
|
decreases expression |
ISO |
2 |
192,839,350 |
192,986,589 |
RGD:6480464 |
CTD |
| G |
Nptn |
neuroplastin |
|
increases expression |
ISO |
8 |
62,389,893 |
62,466,128 |
RGD:6480464 |
CTD |
| G |
Npy1r |
neuropeptide Y receptor Y1 |
|
increases expression |
ISO |
16 |
24,747,183 |
24,756,507 |
RGD:6480464 |
CTD |
| G |
Nsg1 |
neuron specific gene family member 1 |
|
increases expression |
ISO |
14 |
77,931,947 |
77,953,690 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
multiple interactions |
ISO |
4 |
162,435,781 |
162,506,961 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
decreases expression |
ISO |
4 |
162,435,781 |
162,506,961 |
RGD:6480464 |
CTD |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
decreases expression |
ISO |
17 |
11,494,463 |
11,811,654 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
increases expression |
ISO |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Ocln |
occludin |
|
increases expression |
ISO |
2 |
31,317,090 |
31,367,485 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
increases expression |
ISO |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
affects expression |
EXP |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Olr127 |
olfactory receptor 127 |
|
decreases expression |
ISO |
1 |
161,542,787 |
161,543,734 |
RGD:6480464 |
CTD |
| G |
Osm |
oncostatin M |
|
increases expression |
ISO |
14 |
84,857,232 |
84,860,082 |
RGD:6480464 |
CTD |
| G |
Otp |
orthopedia homeobox |
|
increases expression |
ISO |
2 |
25,176,599 |
25,184,585 |
RGD:6480464 |
CTD |
| G |
Oxsr1 |
oxidative-stress responsive 1 |
|
decreases expression |
ISO |
8 |
124,196,599 |
124,286,647 |
RGD:6480464 |
CTD |
| G |
Pak3 |
p21 protein (Cdc42/Rac)-activated kinase 3 |
|
decreases expression |
ISO |
X |
34,734,814 |
34,842,093 |
RGD:6480464 |
CTD |
| G |
Papolb |
poly (A) polymerase beta (testis specific) |
|
increases expression |
ISO |
12 |
12,440,762 |
12,443,108 |
RGD:6480464 |
CTD |
| G |
Pard3 |
par-3 (partitioning defective 3) homolog (C. elegans) |
|
affects expression |
EXP |
19 |
57,015,742 |
57,603,133 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pax7 |
paired box 7 |
|
increases expression |
ISO |
5 |
158,547,765 |
158,648,053 |
RGD:6480464 |
CTD |
| G |
Pbx1 |
pre-B-cell leukemia homeobox 1 |
|
increases expression |
ISO |
13 |
83,839,256 |
84,115,516 |
RGD:6480464 |
CTD |
| G |
Pbx2 |
pre-B-cell leukemia homeobox 2 |
|
decreases expression |
ISO |
20 |
4,253,962 |
4,259,185 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
increases expression |
ISO |
2 |
1,923,309 |
1,970,238 |
RGD:6480464 |
CTD |
| G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
|
increases expression |
ISO |
3 |
131,925,648 |
132,256,178 |
RGD:6480464 |
CTD |
| G |
Pdcd10 |
programmed cell death 10 |
|
multiple interactions |
ISO |
2 |
166,402,652 |
166,445,015 |
RGD:6480464 |
CTD |
| G |
Pdcd10 |
programmed cell death 10 |
|
increases expression |
ISO |
2 |
166,402,652 |
166,445,015 |
RGD:6480464 |
CTD |
| G |
Pdcd6 |
programmed cell death 6 |
|
increases expression |
ISO |
1 |
29,769,911 |
29,785,577 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
multiple interactions |
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
multiple interactions |
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdha2 |
pyruvate dehydrogenase (lipoamide) alpha 2 |
|
increases expression |
ISO |
2 |
238,983,103 |
238,984,651 |
RGD:6480464 |
CTD |
| G |
Pdha2 |
pyruvate dehydrogenase (lipoamide) alpha 2 |
|
increases phosphorylation |
ISO |
2 |
238,983,103 |
238,984,651 |
RGD:6480464 |
CTD |
| G |
Pdpn |
podoplanin |
|
increases expression |
ISO |
5 |
162,142,251 |
162,175,921 |
RGD:6480464 |
CTD |
| G |
Pelo |
pelota homolog (Drosophila) |
|
decreases expression |
ISO |
2 |
45,900,723 |
45,902,491 |
RGD:6480464 |
CTD |
| G |
Penk |
proenkephalin |
|
decreases expression |
ISO |
5 |
17,509,323 |
17,514,265 |
RGD:6480464 |
CTD |
| G |
Pfkfb2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
|
increases expression |
ISO |
13 |
43,624,838 |
43,652,660 |
RGD:6480464 |
CTD |
| G |
Pfkl |
phosphofructokinase, liver |
|
affects expression |
EXP |
20 |
11,009,359 |
11,032,511 |
RGD:6480464 |
CTD |
| G |
Phc1 |
polyhomeotic homolog 1 (Drosophila) |
|
increases expression |
ISO |
4 |
158,736,736 |
158,759,429 |
RGD:6480464 |
CTD |
| G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
|
increases expression |
ISO |
7 |
50,541,011 |
50,543,215 |
RGD:6480464 |
CTD |
| G |
Phlda2 |
pleckstrin homology-like domain, family A, member 2 |
|
increases expression |
ISO |
1 |
203,878,093 |
203,879,038 |
RGD:6480464 |
CTD |
| G |
Phlda3 |
pleckstrin homology-like domain, family A, member 3 |
|
affects expression |
EXP |
13 |
48,789,678 |
48,793,999 |
RGD:6480464 |
CTD |
| G |
Phyh |
phytanoyl-CoA 2-hydroxylase |
|
increases expression |
ISO |
17 |
84,418,173 |
84,435,073 |
RGD:6480464 |
CTD |
| G |
Pigq |
phosphatidylinositol glycan anchor biosynthesis, class Q |
|
increases expression |
ISO |
10 |
15,188,278 |
15,204,292 |
RGD:6480464 |
CTD |
| G |
Pik3c2g |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
|
decreases expression |
ISO |
4 |
176,712,201 |
177,074,095 |
RGD:6480464 |
CTD |
| G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
|
increases expression |
ISO |
5 |
166,735,274 |
166,761,189 |
RGD:6480464 |
CTD |
| G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
increases expression |
ISO |
6 |
50,441,892 |
50,476,931 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
decreases expression |
ISO |
2 |
32,602,673 |
32,675,350 |
RGD:6480464 |
CTD |
| G |
Pik3r5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
|
increases expression |
ISO |
10 |
55,227,872 |
55,248,301 |
RGD:6480464 |
CTD |
| G |
Pitx3 |
paired-like homeodomain 3 |
|
increases expression |
ISO |
1 |
251,355,785 |
251,368,502 |
RGD:6480464 |
CTD |
| G |
Pkib |
protein kinase (cAMP-dependent, catalytic) inhibitor beta |
|
increases expression |
ISO |
20 |
36,655,506 |
36,750,474 |
RGD:6480464 |
CTD |
| G |
Pkm |
pyruvate kinase, muscle |
|
affects expression |
EXP |
8 |
63,486,492 |
63,508,016 |
RGD:6480464 |
CTD |
| G |
Pkn1 |
protein kinase N1 |
|
increases expression |
ISO |
19 |
26,132,497 |
26,160,471 |
RGD:6480464 |
CTD |
| G |
Pla2g4b |
phospholipase A2, group IVB (cytosolic) |
|
increases expression |
ISO |
3 |
106,540,155 |
106,548,519 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
affects expression |
EXP |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
multiple interactions |
ISO |
15 |
3,680,072 |
3,686,232 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
increases expression |
ISO |
15 |
3,680,072 |
3,686,232 |
RGD:6480464 |
CTD |
| G |
Plcb1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
|
affects expression |
EXP |
3 |
122,797,718 |
123,523,675 |
RGD:6480464 |
CTD |
| G |
Plec |
plectin |
|
increases phosphorylation |
ISO |
7 |
114,202,742 |
114,262,385 |
RGD:6480464 |
CTD |
| G |
Plk2 |
polo-like kinase 2 |
|
affects expression |
EXP |
2 |
41,800,745 |
41,806,503 |
RGD:6480464 |
CTD |
| G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
|
increases expression |
ISO |
8 |
97,525,279 |
97,623,152 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
decreases expression |
ISO |
10 |
49,305,835 |
49,335,864 |
RGD:6480464 |
CTD |
| G |
Pnoc |
prepronociceptin |
|
decreases expression |
ISO |
15 |
44,822,635 |
44,835,637 |
RGD:6480464 |
CTD |
| G |
Podxl |
podocalyxin-like |
|
increases expression |
ISO |
4 |
58,611,904 |
58,658,598 |
RGD:6480464 |
CTD |
| G |
Polr1b |
polymerase (RNA) I polypeptide B |
|
increases expression |
ISO |
3 |
116,706,483 |
116,730,946 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
increases expression |
ISO |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pop1 |
processing of precursor 1, ribonuclease P/MRP subunit (S. cerevisiae) |
|
decreases expression |
ISO |
7 |
69,944,414 |
69,979,794 |
RGD:6480464 |
CTD |
| G |
Pou1f1 |
POU class 1 homeobox 1 |
|
increases expression |
ISO |
11 |
2,959,383 |
2,980,545 |
RGD:6480464 |
CTD |
| G |
Pou2f3 |
POU class 2 homeobox 3 |
|
decreases expression |
ISO |
8 |
46,125,421 |
46,208,205 |
RGD:6480464 |
CTD |
| G |
Ppbp |
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
|
multiple interactions |
ISO |
14 |
18,816,434 |
18,817,238 |
RGD:6480464 |
CTD |
| G |
Ppbp |
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
|
increases expression |
ISO |
14 |
18,816,434 |
18,817,238 |
RGD:6480464 |
CTD |
| G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
|
affects expression |
EXP |
1 |
95,994,023 |
95,997,080 |
RGD:6480464 |
CTD |
| G |
Ppp2r5c |
protein phosphatase 2, regulatory subunit B', gamma |
|
multiple interactions |
ISO |
6 |
135,204,405 |
135,299,068 |
RGD:6480464 |
CTD |
| G |
Ppp2r5c |
protein phosphatase 2, regulatory subunit B', gamma |
|
decreases expression |
ISO |
6 |
135,204,405 |
135,299,068 |
RGD:6480464 |
CTD |
| G |
Ppp2r5d |
protein phosphatase 2, regulatory subunit B', delta |
|
increases expression |
ISO |
9 |
10,054,005 |
10,078,501 |
RGD:6480464 |
CTD |
| G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isozyme |
|
multiple interactions |
ISO |
2 |
234,130,176 |
234,409,232 |
RGD:6480464 |
CTD |
| G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isozyme |
|
decreases expression |
ISO |
2 |
234,130,176 |
234,409,232 |
RGD:6480464 |
CTD |
| G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isozyme |
|
affects expression |
EXP |
2 |
234,130,176 |
234,409,232 |
RGD:6480464 |
CTD |
| G |
Ppp4c |
protein phosphatase 4, catalytic subunit |
|
increases expression |
ISO |
1 |
185,961,286 |
185,967,851 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
increases expression |
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
increases expression |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prdx3 |
peroxiredoxin 3 |
|
increases expression |
ISO |
1 |
267,468,371 |
267,481,273 |
RGD:6480464 |
CTD |
| G |
Prex1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
|
affects expression |
EXP |
3 |
157,693,897 |
157,863,943 |
RGD:6480464 |
CTD |
| G |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
|
increases expression |
ISO |
2 |
244,949,303 |
245,035,266 |
RGD:6480464 |
CTD |
| G |
Prkar2a |
protein kinase, cAMP dependent regulatory, type II alpha |
|
increases phosphorylation |
ISO |
8 |
113,746,384 |
113,805,476 |
RGD:6480464 |
CTD |
| G |
Prkcb |
protein kinase C, beta |
|
decreases expression |
ISO |
1 |
181,117,512 |
181,459,856 |
RGD:6480464 |
CTD |
| G |
Prl2a1 |
Prolactin family 2, subfamily a, member 1 |
|
increases expression |
ISO |
17 |
43,470,805 |
43,476,897 |
RGD:6480464 |
CTD |
| G |
Prl6a1 |
prolactin family 6, subfamily a, member 1 |
|
increases expression |
ISO |
17 |
44,267,690 |
44,272,479 |
RGD:6480464 |
CTD |
| G |
Prom2 |
prominin 2 |
|
increases phosphorylation |
ISO |
3 |
115,030,864 |
115,044,987 |
RGD:6480464 |
CTD |
| G |
Prr5l |
proline rich 5 like |
|
affects expression |
EXP |
3 |
86,868,129 |
86,948,468 |
RGD:6480464 |
CTD |
| G |
Prrc2c |
proline-rich coiled-coil 2C |
|
increases phosphorylation |
ISO |
13 |
78,332,572 |
78,400,635 |
RGD:6480464 |
CTD |
| G |
Psma3 |
proteasome (prosome, macropain) subunit, alpha type 3 |
|
affects expression |
EXP |
6 |
93,092,191 |
93,112,167 |
RGD:6480464 |
CTD |
| G |
Psma4 |
proteasome (prosome, macropain) subunit, alpha type 4 |
|
affects expression |
EXP |
8 |
58,508,643 |
58,516,103 |
RGD:6480464 |
CTD |
| G |
Psma6 |
proteasome (prosome, macropain) subunit, alpha type 6 |
|
affects expression |
EXP |
6 |
75,649,844 |
75,667,404 |
RGD:6480464 |
CTD |
| G |
Psmb3 |
proteasome (prosome, macropain) subunit, beta type 3 |
|
affects expression |
EXP |
10 |
86,452,533 |
86,459,616 |
RGD:6480464 |
CTD |
| G |
Psmb4 |
proteasome (prosome, macropain) subunit, beta type 4 |
|
affects expression |
EXP |
2 |
189,778,476 |
189,781,169 |
RGD:6480464 |
CTD |
| G |
Psmb6 |
proteasome (prosome, macropain) subunit, beta type 6 |
|
affects expression |
EXP |
10 |
57,370,397 |
57,372,704 |
RGD:6480464 |
CTD |
| G |
Psmd6 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 |
|
increases expression |
ISO |
15 |
12,650,570 |
12,660,487 |
RGD:6480464 |
CTD |
| G |
Ptgds |
prostaglandin D2 synthase (brain) |
|
increases expression |
ISO |
3 |
3,632,683 |
3,635,617 |
RGD:6480464 |
CTD |
| G |
Ptgis |
prostaglandin I2 (prostacyclin) synthase |
|
increases expression |
ISO |
3 |
158,356,878 |
158,387,984 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
decreases response to substance |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases response to substance |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptpn12 |
protein tyrosine phosphatase, non-receptor type 12 |
|
increases expression |
ISO |
4 |
9,517,642 |
9,589,954 |
RGD:6480464 |
CTD |
| G |
Ptpra |
protein tyrosine phosphatase, receptor type, A |
|
affects expression |
EXP |
3 |
118,061,713 |
118,171,300 |
RGD:6480464 |
CTD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
affects expression |
EXP |
13 |
51,246,163 |
51,357,995 |
RGD:6480464 |
CTD |
| G |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
|
affects expression |
EXP |
5 |
94,069,724 |
94,286,657 |
RGD:6480464 |
CTD |
| G |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
|
decreases expression |
ISO |
15 |
14,449,352 |
15,130,760 |
RGD:6480464 |
CTD |
| G |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
|
affects expression |
EXP |
15 |
14,449,352 |
15,130,760 |
RGD:6480464 |
CTD |
| G |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
|
increases expression |
ISO |
1 |
17,328,563 |
17,752,200 |
RGD:6480464 |
CTD |
| G |
Ptprm |
protein tyrosine phosphatase, receptor type, M |
|
affects expression |
EXP |
9 |
105,784,922 |
106,503,148 |
RGD:6480464 |
CTD |
| G |
Pvrl1 |
poliovirus receptor-related 1 |
|
increases phosphorylation |
ISO |
8 |
46,739,657 |
46,799,051 |
RGD:6480464 |
CTD |
| G |
Rab19 |
RAB19, member RAS oncogene family |
|
increases expression |
ISO |
4 |
66,889,446 |
66,899,175 |
RGD:6480464 |
CTD |
| G |
Rabggtb |
Rab geranylgeranyltransferase, beta subunit |
|
affects expression |
EXP |
2 |
251,852,549 |
251,857,811 |
RGD:6480464 |
CTD |
| G |
Rad17 |
RAD17 homolog (S. pombe) |
|
increases expression |
ISO |
2 |
31,424,504 |
31,454,313 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
multiple interactions |
ISO |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Rag1 |
recombination activating gene 1 |
|
increases expression |
ISO |
3 |
86,780,782 |
86,791,878 |
RGD:6480464 |
CTD |
| G |
Rai14 |
retinoic acid induced 14 |
|
affects expression |
EXP |
2 |
59,923,115 |
60,060,724 |
RGD:6480464 |
CTD |
| G |
Ranbp3 |
RAN binding protein 3 |
|
increases phosphorylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
|
affects expression |
EXP |
2 |
170,472,420 |
170,587,987 |
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rax |
retina and anterior neural fold homeobox |
|
increases expression |
ISO |
18 |
62,567,485 |
62,571,191 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
increases expression |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
increases phosphorylation |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rbl1 |
retinoblastoma-like 1 (p107) |
|
increases expression |
ISO |
3 |
147,734,622 |
147,796,630 |
RGD:6480464 |
CTD |
| G |
Rbl2 |
retinoblastoma-like 2 |
|
multiple interactions |
ISO |
19 |
17,045,131 |
17,092,597 |
RGD:6480464 |
CTD |
| G |
Rbl2 |
retinoblastoma-like 2 |
|
decreases expression |
ISO |
19 |
17,045,131 |
17,092,597 |
RGD:6480464 |
CTD |
| G |
Rbl2 |
retinoblastoma-like 2 |
|
increases expression |
ISO |
19 |
17,045,131 |
17,092,597 |
RGD:6480464 |
CTD |
| G |
Rbm10 |
RNA binding motif protein 10 |
|
increases phosphorylation |
ISO |
X |
12,957,747 |
12,989,619 |
RGD:6480464 |
CTD |
| G |
Rbm39 |
RNA binding motif protein 39 |
|
increases phosphorylation |
ISO |
3 |
146,555,202 |
146,587,650 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases phosphorylation |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
decreases expression |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Rhox5 |
reproductive homeobox 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rlim |
ring finger protein, LIM domain interacting |
|
increases expression |
ISO |
X |
91,969,453 |
91,985,349 |
RGD:6480464 |
CTD |
| G |
Rnf2 |
ring finger protein 2 |
|
increases expression |
ISO |
13 |
66,345,663 |
66,373,826 |
RGD:6480464 |
CTD |
| G |
Rpl27a |
ribosomal protein L27a |
|
increases expression |
ISO |
1 |
167,115,389 |
167,118,407 |
RGD:6480464 |
CTD |
| G |
Rplp1 |
ribosomal protein, large, P1 |
|
increases phosphorylation |
ISO |
8 |
66,046,220 |
66,047,553 |
RGD:6480464 |
CTD |
| G |
Rps12 |
ribosomal protein S12 |
|
increases expression |
ISO |
1 |
22,265,326 |
22,267,482 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
increases phosphorylation |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
|
increases phosphorylation |
ISO |
5 |
151,274,666 |
151,288,007 |
RGD:6480464 |
CTD |
| G |
Rps6ka2 |
ribosomal protein S6 kinase polypeptide 2 |
|
increases expression |
ISO |
1 |
47,424,106 |
47,560,373 |
RGD:6480464 |
CTD |
| G |
Rps6ka4 |
ribosomal protein S6 kinase, polypeptide 4 |
|
increases expression |
ISO |
1 |
209,505,327 |
209,516,071 |
RGD:6480464 |
CTD |
| G |
Rps6ka5 |
ribosomal protein S6 kinase, polypeptide 5 |
|
decreases expression |
ISO |
6 |
124,820,623 |
124,999,790 |
RGD:6480464 |
CTD |
| G |
Rps6ka5 |
ribosomal protein S6 kinase, polypeptide 5 |
|
increases phosphorylation |
ISO |
6 |
124,820,623 |
124,999,790 |
RGD:6480464 |
CTD |
| G |
Rps6ka5 |
ribosomal protein S6 kinase, polypeptide 5 |
|
decreases expression |
ISO |
6 |
124,820,623 |
124,999,790 |
RGD:6480464 |
CTD |
| G |
Rps6ka5 |
ribosomal protein S6 kinase, polypeptide 5 |
|
increases phosphorylation |
ISO |
6 |
124,820,623 |
124,999,790 |
RGD:6480464 |
CTD |
| G |
Rras2 |
related RAS viral (r-ras) oncogene homolog 2 |
|
increases expression |
ISO |
1 |
172,026,262 |
172,097,710 |
RGD:6480464 |
CTD |
| G |
Runx3 |
runt-related transcription factor 3 |
|
increases expression |
ISO |
5 |
153,950,116 |
153,973,141 |
RGD:6480464 |
CTD |
| G |
Rxrg |
retinoid X receptor gamma |
|
increases expression |
ISO |
13 |
83,256,823 |
83,298,724 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
increases expression |
ISO |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
Sag |
S-antigen; retina and pineal gland (arrestin) |
|
decreases expression |
ISO |
9 |
86,759,933 |
86,799,902 |
RGD:6480464 |
CTD |
| G |
Scaf1 |
SR-related CTD-associated factor 1 |
|
increases phosphorylation |
ISO |
1 |
95,475,611 |
95,485,819 |
RGD:6480464 |
CTD |
| G |
Scg2 |
secretogranin II |
|
increases expression |
ISO |
9 |
78,762,661 |
78,767,970 |
RGD:6480464 |
CTD |
| G |
Scgb1a1 |
secretoglobin, family 1A, member 1 (uteroglobin) |
|
increases expression |
ISO |
1 |
211,758,103 |
211,761,651 |
RGD:6480464 |
CTD |
| G |
Scly |
selenocysteine lyase |
|
increases expression |
ISO |
9 |
90,525,575 |
90,546,159 |
RGD:6480464 |
CTD |
| G |
Sdad1 |
SDA1 domain containing 1 |
|
increases phosphorylation |
ISO |
14 |
17,302,948 |
17,329,725 |
RGD:6480464 |
CTD |
| G |
Sema3e |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
|
decreases expression |
ISO |
4 |
16,523,602 |
16,781,878 |
RGD:6480464 |
CTD |
| G |
Sema4d |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
|
increases expression |
ISO |
17 |
19,352,632 |
19,373,179 |
RGD:6480464 |
CTD |
| G |
Serpinb5 |
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
|
decreases expression |
ISO |
13 |
13,037,587 |
13,057,785 |
RGD:6480464 |
CTD |
| G |
Serpine2 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
|
increases expression |
ISO |
9 |
79,091,414 |
79,166,330 |
RGD:6480464 |
CTD |
| G |
Sertad1 |
SERTA domain containing 1 |
|
affects expression |
EXP |
1 |
82,565,982 |
82,569,250 |
RGD:6480464 |
CTD |
| G |
Sf1 |
splicing factor 1 |
|
increases phosphorylation |
ISO |
1 |
209,146,177 |
209,159,459 |
RGD:6480464 |
CTD |
| G |
Sfn |
stratifin |
|
increases alkylation |
ISO |
5 |
151,475,395 |
151,479,996 |
RGD:6480464 |
CTD |
| G |
Sfrp2 |
secreted frizzled-related protein 2 |
|
decreases expression |
ISO |
2 |
175,479,320 |
175,486,865 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
affects expression |
EXP |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Shh |
sonic hedgehog |
|
decreases expression |
ISO |
4 |
2,200,504 |
2,209,657 |
RGD:6480464 |
CTD |
| G |
Siae |
sialic acid acetylesterase |
|
increases expression |
ISO |
8 |
38,854,154 |
38,889,452 |
RGD:6480464 |
CTD |
| G |
Sim1 |
single-minded homolog 1 (Drosophila) |
|
increases expression |
ISO |
20 |
54,908,178 |
54,988,099 |
RGD:6480464 |
CTD |
| G |
Six4 |
SIX homeobox 4 |
|
increases expression |
ISO |
6 |
95,526,293 |
95,539,953 |
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
affects expression |
EXP |
2 |
199,860,341 |
199,879,856 |
RGD:6480464 |
CTD |
| G |
Slc16a7 |
solute carrier family 16, member 7 (monocarboxylic acid transporter 2) |
|
affects expression |
EXP |
7 |
65,210,148 |
65,313,572 |
RGD:6480464 |
CTD |
| G |
Slc18a3 |
solute carrier family 18 (vesicular acetylcholine), member 3 |
|
increases expression |
ISO |
16 |
7,969,738 |
7,972,599 |
RGD:6480464 |
CTD |
| G |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
increases expression |
ISO |
1 |
232,469,746 |
232,549,584 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
increases expression |
ISO |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
increases expression |
ISO |
2 |
58,270,236 |
58,347,613 |
RGD:6480464 |
CTD |
| G |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
|
increases expression |
ISO |
1 |
77,111,082 |
77,125,166 |
RGD:6480464 |
CTD |
| G |
Slc1a6 |
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 |
|
increases expression |
ISO |
7 |
12,393,284 |
12,419,893 |
RGD:6480464 |
CTD |
| G |
Slc20a1 |
solute carrier family 20 (phosphate transporter), member 1 |
|
affects expression |
EXP |
3 |
116,813,990 |
116,828,049 |
RGD:6480464 |
CTD |
| G |
Slc22a5 |
solute carrier family 22 (organic cation/carnitine transporter), member 5 |
|
increases expression |
ISO |
10 |
39,311,729 |
39,338,718 |
RGD:6480464 |
CTD |
| G |
Slc38a2 |
solute carrier family 38, member 2 |
|
affects expression |
EXP |
7 |
135,365,172 |
135,377,341 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
|
decreases expression |
ISO |
5 |
138,300,869 |
138,334,893 |
RGD:6480464 |
CTD |
| G |
Slc7a7 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
|
increases expression |
ISO |
15 |
32,431,748 |
32,471,526 |
RGD:6480464 |
CTD |
| G |
Slc7a8 |
solute carrier family 7 (amino acid transporter light chain, L system), member 8 |
|
increases expression |
ISO |
15 |
32,800,927 |
32,860,797 |
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Slfn1 |
schlafen 1 |
|
multiple interactions |
ISO |
10 |
71,264,746 |
71,265,762 |
RGD:6480464 |
CTD |
| G |
Slfn1 |
schlafen 1 |
|
increases expression |
ISO |
10 |
71,264,746 |
71,265,762 |
RGD:6480464 |
CTD |
| G |
Slk |
STE20-like kinase |
|
increases phosphorylation |
ISO |
1 |
252,954,514 |
253,007,330 |
RGD:6480464 |
CTD |
| G |
Smad3 |
SMAD family member 3 |
|
decreases expression |
ISO |
8 |
67,803,909 |
67,952,056 |
RGD:6480464 |
CTD |
| G |
Smad6 |
SMAD family member 6 |
|
increases expression |
ISO |
8 |
68,144,395 |
68,214,652 |
RGD:6480464 |
CTD |
| G |
Smarcc1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
|
increases phosphorylation |
ISO |
8 |
114,484,491 |
114,609,850 |
RGD:6480464 |
CTD |
| G |
Snrnp70 |
small nuclear ribonucleoprotein 70 (U1) |
|
increases phosphorylation |
ISO |
1 |
95,853,923 |
95,868,393 |
RGD:6480464 |
CTD |
| G |
Snrpc |
small nuclear ribonucleoprotein polypeptide C |
|
increases expression |
ISO |
20 |
6,045,678 |
6,063,842 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
multiple interactions |
ISO |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
increases expression |
ISO |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sp4 |
Sp4 transcription factor |
|
increases expression |
ISO |
6 |
145,553,512 |
145,619,389 |
RGD:6480464 |
CTD |
| G |
Sphk2 |
sphingosine kinase 2 |
|
increases expression |
ISO |
1 |
96,178,615 |
96,182,920 |
RGD:6480464 |
CTD |
| G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
|
increases expression |
ISO |
18 |
37,090,934 |
37,099,835 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Spry1 |
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
|
increases expression |
ISO |
2 |
124,213,692 |
124,218,334 |
RGD:6480464 |
CTD |
| G |
Spry4 |
sprouty homolog 4 (Drosophila) |
|
increases expression |
ISO |
18 |
31,532,680 |
31,547,586 |
RGD:6480464 |
CTD |
| G |
Sptbn1 |
spectrin, beta, non-erythrocytic 1 |
|
increases expression |
ISO |
14 |
111,076,741 |
111,246,286 |
RGD:6480464 |
CTD |
| G |
Sqstm1 |
sequestosome 1 |
|
increases phosphorylation |
ISO |
10 |
35,751,300 |
35,762,630 |
RGD:6480464 |
CTD |
| G |
Srpk2 |
SRSF protein kinase 2 |
|
decreases expression |
ISO |
4 |
6,918,521 |
7,039,871 |
RGD:6480464 |
CTD |
| G |
Srrm1 |
serine/arginine repetitive matrix 1 |
|
increases phosphorylation |
ISO |
5 |
154,113,002 |
154,145,275 |
RGD:6480464 |
CTD |
| G |
Srsf9 |
serine/arginine-rich splicing factor 9 |
|
increases phosphorylation |
ISO |
12 |
42,546,330 |
42,552,590 |
RGD:6480464 |
CTD |
| G |
Ssrp1 |
structure specific recognition protein 1 |
|
increases phosphorylation |
ISO |
3 |
68,272,947 |
68,282,596 |
RGD:6480464 |
CTD |
| G |
St13 |
suppression of tumorigenicity 13 |
|
increases phosphorylation |
ISO |
7 |
119,694,123 |
119,728,936 |
RGD:6480464 |
CTD |
| G |
Stag1 |
stromal antigen 1 |
|
multiple interactions |
ISO |
8 |
105,524,756 |
105,919,971 |
RGD:6480464 |
CTD |
| G |
Stag1 |
stromal antigen 1 |
|
decreases expression |
ISO |
8 |
105,524,756 |
105,919,971 |
RGD:6480464 |
CTD |
| G |
Stag2 |
stromal antigen 2 |
|
increases expression |
ISO |
X |
2,840,102 |
2,970,905 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
increases expression |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases expression |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Surf1 |
surfeit 1 |
|
increases expression |
ISO |
3 |
5,810,638 |
5,813,475 |
RGD:6480464 |
CTD |
| G |
Suv39h1 |
suppressor of variegation 3-9 homolog 1 (Drosophila) |
|
increases expression |
ISO |
X |
26,451,917 |
26,464,885 |
RGD:6480464 |
CTD |
| G |
Svil |
supervillin |
|
affects expression |
EXP |
17 |
60,897,631 |
60,898,874 |
RGD:6480464 |
CTD |
| G |
Syt4 |
synaptotagmin IV |
|
increases expression |
ISO |
18 |
23,805,080 |
23,814,489 |
RGD:6480464 |
CTD |
| G |
Syt8 |
synaptotagmin VIII |
|
increases expression |
ISO |
1 |
202,683,924 |
202,686,122 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
increases expression |
ISO |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
multiple interactions |
ISO |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tbr1 |
T-box, brain, 1 |
|
increases expression |
ISO |
3 |
43,647,046 |
43,655,746 |
RGD:6480464 |
CTD |
| G |
Tbx1 |
T-box 1 |
|
decreases expression |
ISO |
11 |
84,400,980 |
84,410,631 |
RGD:6480464 |
CTD |
| G |
Tbxa2r |
thromboxane A2 receptor |
|
increases expression |
ISO |
7 |
9,867,739 |
9,872,536 |
RGD:6480464 |
CTD |
| G |
Tead1 |
TEA domain family member 1 |
|
increases expression |
ISO |
1 |
170,481,601 |
170,696,621 |
RGD:6480464 |
CTD |
| G |
Tekt1 |
tektin 1 |
|
increases expression |
ISO |
10 |
59,219,929 |
59,248,976 |
RGD:6480464 |
CTD |
| G |
Tenm3 |
teneurin transmembrane protein 3 |
|
increases expression |
ISO |
16 |
46,648,771 |
47,149,524 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
increases expression |
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
decreases expression |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
decreases expression |
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Tgoln2 |
trans-golgi network protein 2 |
|
increases expression |
ISO |
4 |
106,110,153 |
106,117,906 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
increases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Thoc4 |
THO complex 4 |
|
increases expression |
ISO |
10 |
109,984,500 |
109,988,263 |
RGD:6480464 |
CTD |
| G |
Tirap |
toll-interleukin 1 receptor (TIR) domain-containing adaptor protein |
|
increases expression |
ISO |
8 |
34,966,856 |
34,969,727 |
RGD:6480464 |
CTD |
| G |
Tjp2 |
tight junction protein 2 |
|
increases phosphorylation |
ISO |
1 |
227,475,386 |
227,574,457 |
RGD:6480464 |
CTD |
| G |
Tlr1 |
toll-like receptor 1 |
|
increases expression |
ISO |
14 |
46,114,913 |
46,124,820 |
RGD:6480464 |
CTD |
| G |
Tlr2 |
toll-like receptor 2 |
|
increases expression |
ISO |
2 |
175,607,990 |
175,613,992 |
RGD:6480464 |
CTD |
| G |
Tlr3 |
toll-like receptor 3 |
|
increases expression |
ISO |
16 |
50,112,910 |
50,126,371 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
increases expression |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tlx1 |
T-cell leukemia, homeobox 1 |
|
decreases expression |
ISO |
1 |
250,255,343 |
250,261,604 |
RGD:6480464 |
CTD |
| G |
Tlx2 |
T-cell leukemia homeobox 2 |
|
increases expression |
ISO |
4 |
117,279,091 |
117,281,693 |
RGD:6480464 |
CTD |
| G |
Tmpo |
thymopoietin |
|
increases phosphorylation |
ISO |
7 |
28,086,576 |
28,111,800 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
|
increases expression |
ISO |
6 |
136,196,746 |
136,210,410 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
multiple interactions |
ISO |
4 |
162,172,563 |
162,185,252 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
multiple interactions |
ISO |
5 |
163,666,541 |
163,697,484 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnk1 |
tyrosine kinase, non-receptor, 1 |
|
increases phosphorylation |
ISO |
10 |
56,692,319 |
56,698,602 |
RGD:6480464 |
CTD |
| G |
Tnrc15 |
trinucleotide repeat containing 15 |
|
increases phosphorylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tob1 |
transducer of ErbB-2.1 |
|
affects expression |
EXP |
10 |
82,852,405 |
82,854,443 |
RGD:6480464 |
CTD |
| G |
Tomm20 |
translocase of outer mitochondrial membrane 20 homolog (yeast) |
|
increases expression |
ISO |
19 |
56,850,851 |
56,863,167 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
affects expression |
EXP |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases phosphorylation |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53bp1 |
tumor protein p53 binding protein 1 |
|
increases phosphorylation |
ISO |
3 |
107,994,425 |
108,071,133 |
RGD:6480464 |
CTD |
| G |
Tp53bp2 |
tumor protein p53 binding protein, 2 |
|
decreases expression |
ISO |
13 |
98,432,144 |
98,468,555 |
RGD:6480464 |
CTD |
| G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
|
increases expression |
ISO |
5 |
25,008,253 |
25,014,263 |
RGD:6480464 |
CTD |
| G |
Tp63 |
tumor protein p63 |
|
increases expression |
ISO |
11 |
76,900,622 |
77,200,251 |
RGD:6480464 |
CTD |
| G |
Tph1 |
tryptophan hydroxylase 1 |
|
increases expression |
ISO |
1 |
97,186,071 |
97,207,551 |
RGD:6480464 |
CTD |
| G |
Tpi1 |
triosephosphate isomerase 1 |
|
affects expression |
EXP |
4 |
160,933,341 |
160,936,871 |
RGD:6480464 |
CTD |
| G |
Tpo |
thyroid peroxidase |
|
increases expression |
ISO |
6 |
47,954,848 |
48,025,740 |
RGD:6480464 |
CTD |
| G |
Tpt1 |
tumor protein, translationally-controlled 1 |
|
affects expression |
EXP |
15 |
56,752,464 |
56,755,288 |
RGD:6480464 |
CTD |
| G |
Tra2b |
transformer 2 beta homolog (Drosophila) |
|
increases expression |
ISO |
11 |
81,026,729 |
81,044,936 |
RGD:6480464 |
CTD |
| G |
Tradd |
TNFRSF1A-associated via death domain |
|
increases expression |
ISO |
19 |
35,073,150 |
35,075,251 |
RGD:6480464 |
CTD |
| G |
Traf3 |
Tnf receptor-associated factor 3 |
|
increases expression |
ISO |
6 |
135,925,375 |
136,027,270 |
RGD:6480464 |
CTD |
| G |
Traf3 |
Tnf receptor-associated factor 3 |
|
increases expression |
ISO |
6 |
135,925,375 |
136,027,270 |
RGD:6480464 |
CTD |
| G |
Traf4 |
Tnf receptor associated factor 4 |
|
increases expression |
ISO |
10 |
64,471,018 |
64,477,122 |
RGD:6480464 |
CTD |
| G |
Trap1a |
tumor rejection antigen P1A |
|
decreases expression |
ISO |
X |
127,012,848 |
127,017,892 |
RGD:6480464 |
CTD |
| G |
Trappc9 |
trafficking protein particle complex 9 |
|
affects expression |
EXP |
7 |
110,316,543 |
110,796,685 |
RGD:6480464 |
CTD |
| G |
Trex2 |
three prime repair exonuclease 2 |
|
increases expression |
ISO |
X |
159,334,472 |
159,336,080 |
RGD:6480464 |
CTD |
| G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
|
increases expression |
ISO |
8 |
100,770,833 |
100,821,420 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases expression |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Tspan7 |
tetraspanin 7 |
|
increases expression |
ISO |
X |
24,362,332 |
24,383,176 |
RGD:6480464 |
CTD |
| G |
Tssc4 |
tumor suppressing subtransferable candidate 4 |
|
increases expression |
ISO |
1 |
203,344,569 |
203,346,200 |
RGD:6480464 |
CTD |
| G |
Ttc28 |
tetratricopeptide repeat domain 28 |
|
affects expression |
EXP |
12 |
45,479,987 |
45,927,996 |
RGD:6480464 |
CTD |
| G |
Ttf1 |
transcription termination factor, RNA polymerase I |
|
increases expression |
ISO |
3 |
8,067,017 |
8,086,185 |
RGD:6480464 |
CTD |
| G |
Ttk |
Ttk protein kinase |
|
decreases expression |
ISO |
8 |
88,906,665 |
88,944,613 |
RGD:6480464 |
CTD |
| G |
Ttk |
Ttk protein kinase |
|
increases expression |
ISO |
8 |
88,906,665 |
88,944,613 |
RGD:6480464 |
CTD |
| G |
Ube3a |
ubiquitin protein ligase E3A |
|
increases expression |
ISO |
1 |
110,729,142 |
110,816,491 |
RGD:6480464 |
CTD |
| G |
Urod |
uroporphyrinogen decarboxylase |
|
increases expression |
ISO |
5 |
137,296,410 |
137,300,496 |
RGD:6480464 |
CTD |
| G |
Usp25 |
ubiquitin specific peptidase 25 |
|
increases expression |
ISO |
11 |
15,799,829 |
15,907,792 |
RGD:6480464 |
CTD |
| G |
Vamp1 |
vesicle-associated membrane protein 1 |
|
decreases expression |
ISO |
4 |
161,333,661 |
161,340,447 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfb |
vascular endothelial growth factor B |
|
multiple interactions |
ISO |
1 |
209,657,632 |
209,661,271 |
RGD:6480464 |
CTD |
| G |
Vegfc |
vascular endothelial growth factor C |
|
multiple interactions |
ISO |
16 |
40,624,435 |
40,739,692 |
RGD:6480464 |
CTD |
| G |
Vpreb1 |
pre-B lymphocyte 1 |
|
increases expression |
ISO |
11 |
86,146,891 |
86,147,768 |
RGD:6480464 |
CTD |
| G |
Vsx2 |
visual system homeobox 2 |
|
increases expression |
ISO |
6 |
108,638,063 |
108,660,830 |
RGD:6480464 |
CTD |
| G |
Vtn |
vitronectin |
|
increases expression |
ISO |
10 |
64,609,242 |
64,612,322 |
RGD:6480464 |
CTD |
| G |
Wnt1 |
wingless-type MMTV integration site family, member 1 |
|
decreases expression |
ISO |
7 |
137,557,836 |
137,561,883 |
RGD:6480464 |
CTD |
| G |
Ybx1 |
Y box binding protein 1 |
|
increases expression |
ISO |
5 |
139,859,176 |
139,875,840 |
RGD:6480464 |
CTD |
| G |
Yme1l1 |
YME1-like 1 (S. cerevisiae) |
|
increases expression |
ISO |
17 |
96,758,634 |
96,796,686 |
RGD:6480464 |
CTD |
| G |
Yy1 |
YY1 transcription factor |
|
increases expression |
ISO |
6 |
133,132,419 |
133,156,686 |
RGD:6480464 |
CTD |
| G |
Zfp37 |
zinc finger protein 37 |
|
increases expression |
ISO |
5 |
79,119,307 |
79,152,270 |
RGD:6480464 |
CTD |
| G |
Zfp61 |
zinc finger protein 61 |
|
increases expression |
ISO |
1 |
79,504,886 |
79,512,625 |
RGD:6480464 |
CTD |
| G |
Zfp688 |
zinc finger protein 688 |
|
affects expression |
EXP |
1 |
186,684,543 |
186,687,614 |
RGD:6480464 |
CTD |
| G |
Zfp92 |
zinc finger protein 92 |
|
increases expression |
ISO |
X |
159,316,677 |
159,318,948 |
RGD:6480464 |
CTD |
| G |
Zic2 |
Zic family member 2 |
|
increases expression |
ISO |
15 |
107,609,060 |
107,613,169 |
RGD:6480464 |
CTD |
| G |
Zic3 |
Zic family member 3 |
|
increases expression |
ISO |
X |
143,128,118 |
143,139,155 |
RGD:6480464 |
CTD |
| G |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
|
affects expression |
EXP |
16 |
1,037,882 |
1,245,259 |
RGD:6480464 |
CTD |
Term paths to the root
|